Bronchitis, not specified as acute or chronic

J10_BRONCH

bronchitis: An acute or chronic inflammatory process affecting the bronchi. [database_cross_reference: NCIT:C2911]

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J40 Hospital discharge: ICD-9 — 490 Hospital discharge: ICD-8 — 49099 Cause of death: ICD-10 — J40 Cause of death: ICD-9 — 490 Cause of death: ICD-8 — 49099 2 out of 7 registries used, show all original rules.	3845
4. Check minimum number of events None	3845
5. Include endpoints None	3845
6. Filter based on genotype QC (FinnGen only)	3845

Control definitions (FinnGen only)

Control exclude: J10_LOWCHRON

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J40-J47
Name in latin: Bronchitis non specificata utrum acuta an chronica

NAME	J10_BRONCH
CONTROL_EXCLUDE	J10_LOWCHRON
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J40
HD_ICD_9	490
HD_ICD_8	49099
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J40
COD_ICD_9	490
COD_ICD_8	49099
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Bronchitis, not specified as acute or chronic based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	45745	19996	25104
Only index persons	31269	13713	17556
Unadjusted period prevalence (%)
Whole population	0.64	0.57	0.70
Only index persons	0.60	0.50	0.67
Median age at first event (years)
Whole population	42.04	52.72	33.02
Only index persons	30.35	43.02	20.46

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3845	1735	2110
Unadjusted period prevalence (%)	0.78	0.59	0.93
Median age at first event (years)	33.30	38.53	29.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3477: Matched controls
34771

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

49099

ICD-8 Finland

Bronchitis, unspecified

+∞

323.0

1752

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

38.4

323.0

447

133

J45.0

ICD-10 Finland

Predominantly allergic asthma

84.0

323.0

448

R03BA02

ATC

budesonide; inhalant

7.7

323.0

871

1443

R03AC02

ATC

salbutamol; inhalant

4.8

323.0

2163

8938

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

+∞

323.0

1130

R03AK06

ATC

salmeterol and fluticasone; inhalant

10.2

323.0

733

885

4900A

ICD-9 Finland

Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]

+∞

323.0

624

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

93.4

323.0

1158

185

R03BB04

ATC

tiotropium bromide; inhalant

19.7

323.0

516

305

J45.9

ICD-10 Finland

Asthma, unspecified

36.3

323.0

914

338

J45.1

ICD-10 Finland

Nonallergic asthma

150.1

322.2

339

49300

ICD-8 Finland

Asthma, bronchiale

+∞

281.1

266

R03BA05

ATC

fluticasone; inhalant

5.9

260.9

829

1755

R03AC12

ATC

salmeterol; inhalant

54.4

257.2

308

R03DC03

ATC

montelukast; oral

6.7

251.4

705

1264

R03BA01

ATC

beclometasone; inhalant

7.2

242.2

642

1059

H02AB06

ATC

prednisolone; systemic

3.3

230.3

1818

8711

R03AK07

ATC

formoterol and budesonide; inhalant

5.0

223.8

822

2020

J45

ICD-10 Finland

Asthma

14.5

218.8

384

296

R03DA04

ATC

theophylline; systemic, rectal

18.1

211.1

338

206

R96

ICPC

Asthma

15.3

201.1

344

248

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

99.5

187.4

206

R03AC03

ATC

terbutaline; inhalant

5.4

183.4

613

1329

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.9

176.7

852

2658

R03AC13

ATC

formoterol; inhalant

22.0

161.0

240

117

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

56.7

158.2

188

J45.8

ICD-10 Finland

Mixed asthma

143.3

154.7

164

J46

ICD-10 Finland

Status asthmaticus

202.7

150.1

155

J47

ICD-10 Finland

Bronchiectasis

505.4

147.6

146

R03BB01

ATC

ipratropium bromide; inhalant

12.6

137.2

254

216

J01AA02

ATC

doxycycline; systemic

2.7

134.0

2742

20215

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

9.0

133.1

296

357

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

+∞

131.1

125

J01FA06

ATC

roxithromycin; oral

2.5

128.1

1528

8400

H02AB04

ATC

methylprednisolone; systemic

3.7

125.1

627

1961

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

137.1

124.0

132

R03AK08

ATC

formoterol and beclometasone; inhalant

34.2

121.8

160

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

119.4

114

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.7

114.8

987

4461

R03BA08

ATC

ciclesonide; inhalant

6.7

110.3

296

473

H02AB07

ATC

prednisone; oral

3.2

96.5

569

1985

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

6.9

94.4

249

387

UGC12

NOMESCO Finland

Flexible bronchoscopy

4.5

92.4

350

835

R06.0

ICD-10 Finland

Dyspnoea

2.5

88.9

837

3893

J01MA14

ATC

moxifloxacin; systemic

4.0

88.3

387

1059

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.0

79.6

1669

11020

R05

ICD-10 Finland

Cough

2.5

73.6

662

2964

XG410

NOMESCO Finland

Flow-volume spirometry

7.0

73.2

189

284

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

6.6

72.1

193

305

J01FA10

ATC

azithromycin; systemic

1.9

72.1

1834

12831

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

12.5

72.0

132

109

XG474

NOMESCO Finland

Exhalation nntrogen oxide

13.9

71.4

125

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

68.4

1416

9131

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.9

67.0

1380

8860

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

64.8

48609

ICD-8 Finland

Pneumonia, unspecified

7.6

62.9

152

207

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

6.3

62.0

171

281

J01FA09

ATC

clarithromycin; systemic

2.0

61.3

1022

6009

R06AE07

ATC

cetirizine; oral

1.9

60.2

1342

8764

R02

ICPC

Shortness of breath/dyspnoea

3.0

59.4

379

1369

J01MA12

ATC

levofloxacin; systemic

2.3

59.1

664

3290

R01AD09

ATC

mometasone; nasal

1.8

58.5

1352

8914

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

7.1

58.3

148

217

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

155.1

58.1

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.0

57.6

355

1252

R01AD08

ATC

fluticasone; nasal

2.0

55.0

872

4988

1240

FHL

Bronchoscopy

12.4

54.5

100

R06.2

ICD-10 Finland

Wheezing

5.8

53.9

160

289

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

53.3

N02AX02

ATC

tramadol; systemic, rectal

1.8

51.8

1388

9493

R03BC01

ATC

cromoglicic acid; inhalant

14.9

50.9

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.1

50.4

665

3514

R04.2

ICD-10 Finland

Haemoptysis

5.5

50.3

155

293

R03BC03

ATC

nedocromil; inhalant

3.4

49.9

257

793

R03DC01

ATC

zafirlukast; oral

18.1

49.8

J01CA04

ATC

amoxicillin; systemic

1.8

49.5

2578

21423

R03AK11

ATC

formoterol and fluticasone; inhalant

13.4

48.1

J01DA01

ATC

[U] cefalexin; systemic

1.7

47.2

2049

15994

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.3

47.1

259

839

R05

ICPC

Cough

2.0

47.1

668

3625

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

+∞

47.0

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.9

46.9

825

4863

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

8.1

45.9

106

135

R01BA52

ATC

pseudoephedrine, combinations; oral

1.8

45.2

934

5810

C03CA01

ATC

furosemide; systemic

1.8

45.0

952

5966

49109

ICD-8 Finland

Chronic bronchitis, Unspecified

+∞

44.9

J20

ICD-10 Finland

Acute bronchitis

2.8

44.5

315

1207

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.9

44.1

863

5263

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

57.5

43.4

R05FB02

ATC

cough suppressants and expectorants

1.7

43.3

1206

8216

R05FA02

ATC

opium derivatives and expectorants; systemic

1.7

42.4

1242

8577

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

4.9

42.0

142

298

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

2.4

41.9

392

1751

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

+∞

41.7

48509

ICD-8 Finland

Bronchopneumonia, unspecified

7.5

41.6

101

139

R95

ICPC

Chron obstructive pulmonary disease

12.5

41.4

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

6.6

41.4

109

169

A02BC02

ATC

pantoprazole; systemic

1.6

41.1

1986

15670

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.6

41.1

319

1290

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.9

40.9

174

458

XQ800

NOMESCO Finland

Prick test

3.3

40.4

219

702

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

40.0

883

5574

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.7

39.7

181

506

J96.1

ICD-10 Finland

Chronic respiratory failure

10.3

39.7

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

+∞

39.7

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

38.2

38.8

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

38.6

840

5265

SPAT1059

SPAT

Spirometry at the office

4.1

37.3

152

385

N03AX16

ATC

pregabalin; oral

1.8

37.0

745

4546

A02BA02

ATC

ranitidine; systemic

1.9

35.3

644

3794

A02BC03

ATC

lansoprazole; oral

1.7

35.3

897

5871

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

2.6

35.1

269

1078

J42

ICD-10 Finland

Unspecified chronic bronchitis

13.9

34.8

Y0499

ICD-8 Finland

Investigation of respiratory system

7.9

34.6

103

J01FA01

ATC

erythromycin; systemic

2.1

34.5

443

2282

J01FA15

ATC

telithromycin; oral

2.4

34.5

318

1406

J43.9

ICD-10 Finland

Emphysema, unspecified

36.3

33.7

A02BC05

ATC

esomeprazole; systemic

1.6

33.0

1196

8594

R01AD12

ATC

fluticasone furoate; nasal

1.7

32.5

819

5330

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

10.9

32.1

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

31.3

49309

ICD-8 Finland

Asthma, Unspecified

+∞

31.3

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

31.2

542

3128

R51.80

ICD-10 Finland

Headache

2.0

31.0

427

2257

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

12.1

30.6

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.5

30.3

147

433

51899

ICD-8 Finland

Bronchiectasis

+∞

30.2

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

30.0

398

2072

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

29.9

1048

7424

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.4

29.8

110

254

M03BX02

ATC

tizanidine; oral

1.5

29.8

1863

15083

N06AB04

ATC

citalopram; systemic

1.7

29.7

672

4217

XG405

NOMESCO Finland

Education on PEF monitoring

10.7

29.4

G47.3

ICD-10 Finland

Sleep apnoea

1.8

29.1

620

3815

R05CB01

ATC

acetylcysteine; inhalant, oral

6.6

29.0

118

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

28.8

617

3805

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.8

28.6

124

333

SPAT1058

SPAT

PEF monitoring instruction

2.7

28.4

205

793

J01DB01

ATC

cefalexin; oral

1.5

28.3

2569

22460

49308

ICD-8 Finland

Asthma, Alia definita

+∞

28.2

C07AB07

ATC

bisoprolol; oral

1.5

28.0

1383

10577

J41.0

ICD-10 Finland

Simple chronic bronchitis

33.0

27.8

A02BC01

ATC

omeprazole; systemic

1.6

27.7

826

5591

R50.9

ICD-10 Finland

Fever, unspecified

1.9

27.7

441

2456

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

27.4

374

1965

R06AX22

ATC

ebastine; oral

1.9

27.3

462

2632

M54.5

ICD-10 Finland

Low back pain

1.6

27.0

940

6610

R03BB02

ATC

oxitropium bromide; inhalant

21.9

26.9

R01AD05

ATC

budesonide; nasal

2.5

26.7

227

961

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

26.6

525

3149

J01MA02

ATC

ciprofloxacin; systemic

1.5

26.2

1179

8796

J01DA06

ATC

[U] cefuroxime; systemic

1.9

26.2

449

2569

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

3.0

26.1

157

542

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

8.5

26.0

SPAT1254

SPAT

Administration of medicine

1.9

26.0

445

2541

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.3

25.9

249

1119

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.8

25.8

188

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.7

25.7

548

3361

R06AX27

ATC

desloratadine; oral

1.6

25.3

687

4518

E0000UV

ATC

1.5

25.2

1108

8205

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

25.1

696

4604

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.2

24.9

280

1357

R81

ICPC

Pneumonia

3.5

24.8

119

348

R01AD11

ATC

triamcinolone; nasal

2.2

24.7

257

1202

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

24.6

813

5625

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.5

24.6

118

346

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

24.5

24.3

M79.6

ICD-10 Finland

Pain in limb

1.5

24.3

987

7166

R01AD01

ATC

beclometasone; nasal

1.8

24.2

420

2407

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

22.9

23.9

J01FF01

ATC

clindamycin; systemic

1.6

23.8

792

5478

R06AX13

ATC

loratadine; oral

1.9

23.6

402

2290

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

26.9

23.5

7860A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]

9.9

23.5

P01AB01

ATC

metronidazole; oral, rectal

1.5

23.4

1091

8152

R29

ICPC

Respiratory symptom/complaint other

2.6

23.2

180

724

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

23.2

905

6495

N02BE01

ATC

paracetamol; systemic, rectal

1.5

23.2

2662

23797

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

24.8

23.0

49101

ICD-8 Finland

Chronic bronchitis, Nonpurulenta (simplex)

+∞

22.9

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

+∞

22.9

4940A

ICD-9 Finland

Bronchiectasis[BRONCHIECTASIAE]

+∞

22.9

R03CC02

ATC

salbutamol; systemic

3.0

22.9

135

460

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

22.8

415

2414

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

11.5

22.6

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.5

22.6

189

792

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

22.5

350

1930

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

22.2

1335

10478

49104

ICD-8 Finland

Chronic bronchitis, Cum emphysemate

+∞

21.9

N05BA01

ATC

diazepam; systemic, rectal

1.8

21.8

403

2357

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

21.4

493

3082

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

4.9

21.4

144

SPAT1263

SPAT

Sampling

1.4

21.4

1221

9468

50709

ICD-8 Finland

Hay fever, Unspecified

9.3

21.3

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.5

21.1

164

662

N05BA04

ATC

oxazepam; oral

1.6

20.8

716

4971

J37.0

ICD-10 Finland

Chronic laryngitis

3.5

20.8

100

295

A03FA02

ATC

cisapride; oral, rectal

2.1

20.7

243

1198

N06AA09

ATC

amitriptyline; systemic

2.0

20.6

292

1552

R03AC04

ATC

fenoterol; inhalant

30.2

20.5

N03AX12

ATC

gabapentin; oral

1.7

20.5

435

2651

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

20.4

1041

7879

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

20.3

850

6169

A07AA02

ATC

nystatin; oral

2.4

20.3

185

811

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

20.2

668

4593

50301

ICD-8 Finland

Chronic sinusitis, Maxillaris NUD

5.9

20.1

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

20.1

548

3588

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

20.0

242

1207

4939A

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]

+∞

19.8

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

19.7

490

3129

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

19.6

666

4603

A03

ICPC

Fever

1.7

19.3

424

2611

UJF32

NOMESCO Finland

Coloscopy

1.5

19.3

711

5010

A01AB09

ATC

miconazole; local oral

2.0

19.2

242

1229

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

5.7

19.1

R74

ICPC

Upper respiratory infection acute

1.5

19.1

713

5033

M25.5

ICD-10 Finland

Pain in joint

1.5

19.1

742

5289

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

19.1

286

1554

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

19.1

377

2248

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

19.0

239

1213

R03DA05

ATC

aminophylline; systemic, rectal

10.1

18.8

L28

ICPC

Limited function/disability (L)

1.7

18.6

438

2748

78310

ICD-8 Finland

Symptoms referable to respiratory system, Haemoptysis

14.2

18.5

R42

ICD-10 Finland

Dizziness and giddiness

1.6

18.5

609

4172

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

18.5

430

2691

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.8

18.4

121

442

R03CC03

ATC

terbutaline; systemic

4.5

18.4

146

N05CF01

ATC

zopiclone; oral

1.4

18.1

950

7191

A02BA04

ATC

nizatidine; systemic

2.0

18.0

244

1276

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

17.9

314

1801

C01DA14

ATC

isosorbide mononitrate; oral

1.6

17.9

474

3071

J02AC01

ATC

fluconazole; systemic

1.4

17.9

1004

7697

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

17.9

623

4324

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

5.2

17.8

107

7862A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Cough

7.9

17.7

R53

ICD-10 Finland

Malaise and fatigue

1.6

17.7

583

3992

R13

ICD-10 Finland

Dysphagia

2.2

17.6

183

855

J30.3

ICD-10 Finland

Other allergic rhinitis

3.4

17.6

263

R07.3

ICD-10 Finland

Other chest pain

1.9

17.5

264

1436

N06AX21

ATC

duloxetine; oral

1.8

17.5

290

1631

GD1AD

NOMESCO Finland

Thorax CT examination

2.7

17.5

122

465

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

17.3

394

2448

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

21.0

17.3

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.0

17.2

102

351

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

17.2

732

5303

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

17.1

608

4234

M01AE02

ATC

naproxen; oral, rectal

1.4

17.0

1616

13540

4451

FHL

Guitar cutting

3.1

17.0

309

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.4

17.0

249

7863A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Haemoptysis

16.0

17.0

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.4

17.0

145

618

R78

ICPC

Acute bronchitis/bronchiolitis

3.8

16.9

188

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

16.9

195

955

4910A

ICD-9 Finland

Chronic bronchitis, Simple chronic bronchitis

+∞

16.7

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.3

16.6

159

716

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

4.7

16.5

121

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

16.3

262

1457

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

16.3

429

2771

N05CD07

ATC

temazepam; oral

1.7

16.2

377

2352

XG466

NOMESCO Finland

Sleep oxymetry

3.0

16.2

313

M48.0

ICD-10 Finland

Spinal stenosis

1.7

16.1

325

1945

N02AC04

ATC

dextropropoxyphene; oral

2.5

16.0

132

551

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

16.0

195

976

R06AE09

ATC

levocetirizine; oral

1.7

16.0

344

2104

B01AA03

ATC

warfarin; systemic

1.5

15.9

591

4149

TGC00

NOMESCO Finland

Bronchial lavation

3.3

15.8

242

R03BB06

ATC

glycopyrronium bromide; inhalant

60.3

15.8

N06AA12

ATC

doxepin; systemic

2.2

15.7

163

762

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

33.5

15.7

SPAT1262

SPAT

Handing over of treatment supplies

1.6

15.7

496

3357

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

15.6

419

2716

4911A

ICD-9 Finland

Chronic bronchitis, Mucopurulent chronic bronchitis

+∞

15.6

49102

ICD-8 Finland

Chronic bronchitis, Purulenta

+∞

15.6

R60.0

ICD-10 Finland

Localized oedema

1.8

15.6

286

1665

K30

ICD-10 Finland

Functional dyspepsia

1.8

15.5

271

1549

R49.01

ICD-10 Finland

Functional dysphonia

3.2

15.5

251

A10BA02

ATC

metformin; oral

1.4

15.5

766

5705

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

15.4

193

979

G44.2

ICD-10 Finland

Tension-type headache

1.7

15.4

325

1975

E000001

ATC

1.5

15.4

543

3766

R05CB03

ATC

carbocisteine; oral

3.3

15.2

228

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.5

15.0

119

486

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

15.0

1131

9066

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

15.0

234

1289

N06AX11

ATC

mirtazapine; oral

1.4

14.9

872

6689

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

14.9

277

1619

N02AA05

ATC

oxycodone; systemic

1.6

14.9

399

2587

S06.0

ICD-10 Finland

Concussion

1.7

14.8

291

1730

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

14.7

277

1625

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

8.7

14.7

N05BB01

ATC

hydroxyzine; systemic

2.1

14.6

172

852

4919X

ICD-9 Finland

Chronic bronchitis, Unspecified chronic bronchitis

+∞

14.6

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

14.4

381

2461

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

14.4

828

6330

R03AC18

ATC

indacaterol; inhalant

15.4

14.4

M01AH02

ATC

rofecoxib; oral

1.6

14.3

361

2301

46401

ICD-8 Finland

Acute laryngitis and tracheitis, Laryngitis acuta (subglottica)

5.1

14.2

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

14.1

361

2311

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

14.1

548

3876

C01CA24

ATC

epinephrine; parenteral

2.2

14.0

138

629

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

14.0

753

5682

AA1AD

NOMESCO Finland

CT of head and brain

1.5

14.0

638

4662

T90

ICPC

Diabetes non-insulin dependent

1.5

14.0

586

4214

J33.0

ICD-10 Finland

Polyp of nasal cavity

3.1

13.9

255

R11

ICD-10 Finland

Nausea and vomiting

1.8

13.8

222

1236

SPAT1310

SPAT

Counselling related to known health issue

1.4

13.7

827

6363

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.0

13.7

184

960

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

13.7

762

5782

R06AX12

ATC

terfenadine; oral

2.3

13.7

129

580

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

13.7

1079

8685

N05AH04

ATC

quetiapine; oral

1.5

13.7

449

3058

N06AB06

ATC

sertraline; oral

1.7

13.6

287

1740

R09

ICPC

Sinus symptom/complaint

2.0

13.6

177

912

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

5.1

13.6

N06AB03

ATC

fluoxetine; oral

1.7

13.5

319

1999

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

13.5

513

3610

A01AB10

ATC

natamycin; local oral

2.8

13.4

325

A06AD11

ATC

lactulose; oral

1.5

13.4

423

2856

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

13.4

275

1658

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

13.3

286

1744

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

13.2

1055

8497

N06AX16

ATC

venlafaxine; oral

1.6

13.1

344

2219

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

13.1

210

1167

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

13.0

253

1499

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

13.0

309

1940

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.6

12.9

380

A01AB04

ATC

amphotericin B; local oral

2.1

12.9

138

658

R05DB20

ATC

other cough suppressants - combinations

2.0

12.8

154

769

C08DA01

ATC

verapamil; systemic

2.3

12.8

114

499

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

12.7

467

3261

M04AA01

ATC

allopurinol; systemic

1.6

12.7

353

2308

D07AC01

ATC

betamethasone; topical

1.4

12.7

912

7218

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

12.6

740

5658

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

12.6

193

1056

L17

ICPC

Foot/toe symptom/complaint

1.4

12.6

621

4601

SPAT1216

SPAT

Assessment of functional ability

1.5

12.6

407

2761

L03

ICPC

Low back symptom/complaint

1.4

12.6

606

4471

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.7

12.5

325

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

12.5

731

5586

L02

ICPC

Back symptom/complaint

1.8

12.5

220

1265

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

12.5

394

2660

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

12.4

604

4462

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

12.4

280

1732

R05DB05

ATC

pentoxyverine; oral, rectal

2.4

12.4

108

466

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

12.3

300

1899

J01MA01

ATC

ofloxacin; systemic

1.7

12.2

259

1572

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

12.2

726

5565

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

15.9

12.1

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

12.1

237

1406

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

26.8

12.0

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

18.1

12.0

E66.8

ICD-10 Finland

Other obesity

2.2

12.0

124

582

R03AC19

ATC

olodaterol; inhalant

46.8

11.9

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

11.8

131

634

4640A

ICD-9 Finland

Acute laryngitis and tracheitis, Acute laryngitis

6.4

11.8

J01DA08

ATC

[U] cefaclor; oral

1.7

11.8

250

1518

40199

ICD-8 Finland

Essential benign hypertension

2.8

11.8

267

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

11.7

1297

10909

J32.4

ICD-10 Finland

Chronic pansinusitis

4.8

11.7

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

11.7

174

943

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

11.7

613

4589

M01AB05

ATC

diclofenac; systemic, rectal

1.3

11.6

1944

17267

51900

ICD-8 Finland

Other diseases of respiratory system, Atelectasis pulmonis

30.1

11.6

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

3.0

11.6

213

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.9

11.6

123

R03BB07

ATC

umeclidinium bromide; inhalant

12.6

11.6

D02AE01

ATC

carbamide; topical

1.8

11.6

183

1014

T78.4

ICD-10 Finland

Allergy, unspecified

2.3

11.6

107

478

L20.0

ICD-10 Finland

Besnier prurigo

2.0

11.6

142

716

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

11.6

331

2182

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

11.5

1052

8614

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

11.5

1586

13736

5191A

ICD-9 Finland

Other diseases of respiratory system, Other diseases of trachea and bronchus, not elsewhere classified

120.4

11.4

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

11.4

198

1134

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

11.4

394

2714

C01AA05

ATC

digoxin; systemic

1.7

11.3

249

1531

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

11.3

204

1180

Y1202

ICD-8 Finland

Skin tests, Allergy tests

11.8

11.3

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.5

11.3

355

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

11.3

326

2150

N05BA12

ATC

alprazolam; oral

1.6

11.3

277

1755

M79.1

ICD-10 Finland

Myalgia

1.6

11.2

309

2018

R52.9

ICD-10 Finland

Pain, unspecified

1.8

11.1

206

1200

79388

ICD-8 Finland

Observation, without need for further medical care, Morbi alii definiti

5.7

11.1

M54.2

ICD-10 Finland

Cervicalgia

1.8

11.1

179

1000

A46

ICD-10 Finland

Erysipelas

1.5

11.1

368

2511

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

11.0

622

4714

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

11.0

568

4234

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

11.0

164

892

E000002

ATC

1.6

10.9

278

1775

C03DA01

ATC

spironolactone; oral

1.6

10.9

276

1762

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

10.9

249

1548

R28

ICPC

Limited function/disability (R)

4.8

10.8

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

10.8

333

2232

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

10.8

174

970

R05DA01

ATC

ethylmorphine; oral

1.7

10.8

212

1262

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

10.7

701

5440

R79

ICPC

Chronic bronchitis

21.5

10.7

J01DC02

ATC

cefuroxime; systemic

1.9

10.7

152

814

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

10.6

180

1020

UJD02

NOMESCO Finland

Gastroscopy

2.0

10.6

126

631

J33.8

ICD-10 Finland

Other polyp of sinus

3.4

10.5

150

SPAT1229

SPAT

Assessment of need for aid

1.7

10.5

213

1280

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

10.5

132

673

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.4

10.5

356

I50.0

ICD-10 Finland

Congestive heart failure

1.8

10.4

191

1113

348

Kela drug reimbursment

Roflumilast

+∞

10.4

A28

ICPC

Limited function/disability NOS

1.5

10.4

381

2653

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.2

10.4

108

510

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

10.3

537

4005

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

10.3

139

731

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.0

10.3

132

680

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

10.2

1482

12842

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.9

10.2

148

795

D07AA02

ATC

hydrocortisone; topical

1.5

10.2

329

2228

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

10.2

933

7614

S80.0

ICD-10 Finland

Contusion of knee

1.8

10.1

163

910

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.9

10.1

148

801

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

10.0

187

1094

R52.2

ICD-10 Finland

Other chronic pain

2.4

10.0

358

R01AC01

ATC

cromoglicic acid; nasal

2.3

10.0

386

R03BB05

ATC

aclidinium bromide; inhalant

40.2

10.0

R32

ICD-10 Finland

Unspecified urinary incontinence

2.5

10.0

295

SPAT1325

SPAT

Vaccination

1.3

9.9

854

6901

SPAT1301

SPAT

No procedures

1.3

9.9

823

6619

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

9.9

427

3073

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

9.9

1934

17349

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.3

9.9

393

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

9.8

429

3095

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

9.8

226

1409

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

9.8

271

1767

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

9.8

411

2945

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

9.7

407

2916

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

9.7

1042

8679

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

9.7

177

1029

5301A

ICD-9 Finland

Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]

5.3

9.6

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

9.6

329

2260

A02BX02

ATC

sucralfate; oral

2.0

9.6

118

598

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

9.6

176

1028

M02AA07

ATC

piroxicam; topical

1.3

9.5

985

8157

R05CB02

ATC

bromhexine; systemic

3.1

9.5

163

AN1

Coronary angiography

1.5

9.5

299

2015

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

9.5

349

2436

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.1

9.4

106

517

D07AC13

ATC

mometasone; topical

1.3

9.4

745

5942

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

9.4

111

555

A03CA02

ATC

clidinium and psycholeptics; oral

1.8

9.4

164

943

5198X

ICD-9 Finland

Other diseases of respiratory system, not elsewhere classified

+∞

9.4

49000

ICD-8 Finland

+∞

9.4

R04

ICPC

Breathing problem other

2.3

9.4

353

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

9.3

511

3843

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

9.3

181

1076

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

9.3

270

1786

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.0

9.3

166

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

3.4

9.2

123

4224

FHL

Endonasal anthrostomy

4.1

9.2

WX110

NOMESCO Finland

Local anesthesy

1.2

9.2

1907

17153

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.1

9.2

462

N03AE01

ATC

clonazepam; systemic

1.8

9.2

145

806

N03AG01

ATC

valproic acid; systemic, rectal

1.8

9.1

158

904

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

9.1

292

1975

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

9.1

145

809

S01GX02

ATC

levocabastine; ophthalmic

1.9

9.1

139

764

WX722

NOMESCO Finland

PEEP

1.9

9.1

121

634

48099

ICD-8 Finland

Viral pneumonia

8.3

9.0

S97

ICPC

Chronic ulcer skin

1.9

9.0

133

723

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

5.9

9.0

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

15.6

9.0

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

9.0

279

1874

78330

ICD-8 Finland

Symptoms referable to respiratory system, Cough

9.0

B01AB05

ATC

enoxaparin; parenteral

1.3

9.0

763

6139

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

3.3

9.0

131

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

9.0

233

4226

FHL

Posterior radical surgery and possible etmoidectomy

4.9

9.0

G43.9

ICD-10 Finland

Migraine, unspecified

1.9

9.0

118

616

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

8.9

130

704

XG460

NOMESCO Finland

Short time oxymetry

3.1

8.9

149

SPAT1240

SPAT

Therapeutic discussion

1.6

8.9

247

1615

48499

ICD-8 Finland

Acute interstitial pneumonia

12.5

8.9

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

8.9

230

1479

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.1

8.8

437

M01AH05

ATC

etoricoxib; oral

1.2

8.8

1589

14043

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

8.8

329

2304

S18

ICPC

Laceration/cut

1.3

8.7

1071

9045

4122

FHL

Tympanostomy (tympanic tube)

3.5

8.7

113

SPAT1312

SPAT

General health counselling

1.3

8.7

804

6545

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

8.7

578

4486

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

8.7

150

860

A10AE04

ATC

insulin glargine; parenteral

1.5

8.6

251

1662

A12BA01

ATC

potassium chloride; oral

1.8

8.6

135

748

J01AA04

ATC

lymecycline; systemic

1.5

8.6

306

2117

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

8.6

115

603

C09CA01

ATC

losartan; oral

1.3

8.6

592

4620

XF402

NOMESCO Finland

ECG with work load test

1.5

8.5

269

1813

4742A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Adenoid vegetations

3.0

8.5

159

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.6

8.5

105

N05CF02

ATC

zolpidem; oral

1.4

8.5

438

3260

Z00.8

ICD-10 Finland

Other general examinations

1.7

8.5

176

1066

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.5

8.4

256

1712

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

8.4

305

XQ802

NOMESCO Finland

Epicutan test

2.1

8.4

434

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

8.4

172

1038

R51.81

ICD-10 Finland

Facial pain NOS

2.7

8.4

217

N30.0

ICD-10 Finland

Acute cystitis

1.5

8.4

310

2165

Z00.0

ICD-10 Finland

General medical examination

1.4

8.4

457

3432

N03AF01

ATC

carbamazepine; oral, rectal

1.8

8.3

131

729

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

8.3

325

2291

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

8.3

190

1182

R03DX07

ATC

roflumilast; oral

+∞

8.3

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.4

8.3

300

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

8.3

599

4705

J01EA01

ATC

trimethoprim; systemic

1.3

8.3

623

4923

A04

ICPC

Weakness/tiredness general

1.5

8.3

309

2162

N07BA03

ATC

varenicline; oral

1.9

8.2

122

663

SPAT1234

SPAT

Support of social functional capacity

1.8

8.2

141

806

J34.2

ICD-10 Finland

Deviated nasal septum

1.8

8.2

135

760

H03AA01

ATC

levothyroxine sodium; systemic

1.3

8.2

542

4199

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.4

8.2

266

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.5

8.2

240

F34.1

ICD-10 Finland

Dysthymia

2.1

8.2

402

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.6

8.2

215

78329

ICD-8 Finland

Symptoms referable to respiratory system, Dyspnoea alia sive NUD

6.5

8.2

C08CA01

ATC

amlodipine; oral

1.3

8.2

913

7612

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

8.1

101

516

SPAT1260

SPAT

Consultation of another employee

1.4

8.1

439

3291

J01MA06

ATC

norfloxacin; oral

1.4

8.1

341

2444

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.9

8.1

164

N03AX09

ATC

lamotrigine; oral

1.9

8.1

111

590

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

8.1

109

576

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

2.3

8.0

301

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

8.0

503

3865

R35

ICD-10 Finland

Polyuria

1.7

8.0

153

904

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

8.0

311

2191

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.1

8.0

423

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.3

8.0

Z51.6

ICD-10 Finland

Desensitization to allergens

5.3

8.0

A02BC04

ATC

rabeprazole; oral

1.6

8.0

196

1246

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.3

7.9

316

N06AB10

ATC

escitalopram; oral

1.4

7.9

486

3719

UKC02

NOMESCO Finland

Cystoscopy

1.4

7.9

409

3043

M01AX17

ATC

nimesulide; oral

1.3

7.9

633

5048

3810A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media

6.6

7.9

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.0

7.9

458

A02BA03

ATC

famotidine; systemic

1.9

7.9

109

580

J32

ICD-10 Finland

Chronic sinusitis

5.1

7.8

SPAT1211

SPAT

Application of soft bandage

1.6

7.8

222

1459

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.7

7.8

I45.9

ICD-10 Finland

Conduction disorder, unspecified

4.3

7.8

1450

FHL

Otomicroscopy

8.5

7.8

M05BA04

ATC

alendronic acid; oral

1.6

7.8

197

1259

SPAT1057

SPAT

Peak expiratory flow measurement

3.2

7.8

119

A01

ICPC

Pain general/multiple sites

1.6

7.8

176

1095

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.1

7.8

380

SPAT1167

SPAT

Insertion of urinary catheter

2.1

7.7

393

L08

ICPC

Shoulder symptom/complaint

1.4

7.7

440

3330

E66.9

ICD-10 Finland

Obesity, unspecified

2.2

7.7

361

A10BH01

ATC

sitagliptin; oral

1.5

7.7

228

1520

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

7.6

226

1500

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

7.6

217

1429

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.5

7.6

223

1478

S22.3

ICD-10 Finland

Fracture of rib

1.7

7.6

160

975

XA402

NOMESCO Finland

ENMG

2.3

7.6

297

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

7.6

418

3140

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

7.6

388

2879

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

7.6

107

573

SPAT1153

SPAT

Removal of sutures

1.3

7.6

797

6579

C10AA01

ATC

simvastatin; oral

1.2

7.6

1116

9594

J01CA02

ATC

pivampicillin; oral

2.1

7.6

390

L01

ICPC

Neck symptom/complaint

1.4

7.6

307

2183

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

7.6

103

546

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.6

7.6

198

1278

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.4

7.6

252

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.2

7.6

356

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

7.6

201

1303

R03DB04

ATC

theophylline and adrenergics; systemic

25.0

7.6

R00.2

ICD-10 Finland

Palpitations

1.7

7.6

159

967

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.8

7.5

118

655

72820

ICD-8 Finland

Vertebrogenic pain syndrome, Diffuse syndrome cerviocobrachial

8.9

7.5

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

7.5

512

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.0

7.5

485

R06.4

ICD-10 Finland

Hyperventilation

2.9

7.5

149

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

4.0

7.4

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

7.4

260

1794

SPAT1104

SPAT

Monitoring of emergency patient

1.6

7.4

163

1007

41399

ICD-8 Finland

Angina pectoris, Without mention of hypertensive disease

3.2

7.4

118

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

7.4

166

1029

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.9

7.4

151

WZA90

NOMESCO Finland

Other doctors statement

1.3

7.4

548

4317

K59.0

ICD-10 Finland

Constipation

1.7

7.4

140

827

C08DB01

ATC

diltiazem; oral

1.7

7.4

140

827

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

7.4

147

883

4111X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]

3.0

7.4

130

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

7.3

754

6205

M02AA10

ATC

ketoprofen; topical

1.4

7.3

398

2987

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

2.5

7.3

207

J01GB01

ATC

tobramycin; inhalant, parenteral

+∞

7.3

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

2.8

7.3

153

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.9

7.3

527

J01CA08

ATC

pivmecillinam; oral

1.3

7.3

893

7512

A11

ICPC

Chest pain NOS

1.6

7.3

176

1117

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.2

7.3

328

R21

ICPC

Throat symptom/complaint

1.4

7.2

434

3306

R49.08

ICD-10 Finland

Other specified dysphonia

2.8

7.2

154

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.0

7.2

463

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

7.2

154

943

N04BC05

ATC

pramipexole; oral

1.6

7.2

167

1044

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

7.2

144

867

ZXA10

NOMESCO Finland

Bilateral

1.3

7.2

446

3420

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.4

7.2

239

SPAT1097

SPAT

Recording of ECG

1.4

7.2

357

2639

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

7.2

115

645

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

7.2

145

873

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.8

7.2

124

713

6453

FHL

Radical surgery of hemorrhoids

2.4

7.1

248

K20

ICD-10 Finland

Oesophagitis

2.8

7.1

149

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.6

7.1

196

5901A

ICD-9 Finland

Infections of kidney, Acute pyelonephritis

3.3

7.1

100

N06AX03

ATC

mianserin; oral

1.8

7.1

120

686

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

2.2

7.1

294

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

7.1

1381

12212

XKC03

NOMESCO Finland

Water cystometry

2.2

7.1

315

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.3

7.1

274

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

7.0

149

909

H25.8

ICD-10 Finland

Other senile cataract

1.5

7.0

264

1851

J20.8

ICD-10 Finland

Acute bronchitis due to other specified organisms

8.8

7.0

F61.0

ICD-10 Finland

Mixed personality disorders

2.7

7.0

167

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

7.0

167

1056

M10.9

ICD-10 Finland

Gout, unspecified

1.7

7.0

149

914

WX290

NOMESCO Finland

Other blockade of nerve

1.2

7.0

1113

9630

H66.9

ICD-10 Finland

Otitis media, unspecified

1.8

7.0

110

615

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

7.0

427

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

7.0

291

2081

Z71.8

ICD-10 Finland

Other specified counselling

1.3

7.0

545

4322

R06AX26

ATC

fexofenadine; oral

1.7

7.0

130

768

N06AX05

ATC

trazodone; oral

2.3

7.0

277

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

7.0

335

2460

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

6.9

108

603

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

6.9

113

638

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

6.9

297

2136

-1

NOMESCO Finland

1.3

6.9

828

6940

00920

ICD-8 Finland

Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)

2.0

6.9

462

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

6.9

207

1384

SPAT1252

SPAT

Overall medication plan or its review

1.6

6.9

170

1083

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.1

6.9

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

6.9

521

4117

KMAK

NOMESCO Finland

1.2

6.8

1382

12246

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

6.8

147

902

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

6.8

361

2697

B01AC04

ATC

clopidogrel; oral

1.4

6.8

374

2811

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

6.8

116

666

N17

ICPC

Vertigo/dizziness

1.5

6.8

248

1728

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

6.8

642

5224

50300

ICD-8 Finland

Chronic sinusitis, Maxillaris cum empyemate

4.2

6.8

R09.1

ICD-10 Finland

Pleurisy

2.7

6.8

166

J15.8

ICD-10 Finland

Other bacterial pneumonia

4.0

6.8

R33

ICD-10 Finland

Retention of urine

1.5

6.7

195

1291

R06.5

ICD-10 Finland

Mouth breathing

1.5

6.7

201

1340

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

3.7

6.7

Q32.21

ICD-10 Finland

Secondary congenital bronchomalacia

16.7

6.7

ACC51

NOMESCO Finland

Release of median nerve

1.6

6.7

164

1044

R06AX11

ATC

astemizole; oral

2.2

6.7

290

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.0

6.7

425

M01AB51

ATC

indometacin, combinations; oral, rectal

2.1

6.7

324

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.2

6.7

303

A10BJ06

ATC

semaglutide; parenteral

2.1

6.6

338

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

6.6

222

1520

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

6.6

253

1777

R52.0

ICD-10 Finland

Acute pain

2.0

6.6

377

30180

ICD-8 Finland

Personality disorders, Immatura

5.2

6.6

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

6.6

302

2202

R04.0

ICD-10 Finland

Epistaxis

1.6

6.6

167

1073

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

8.7

6.5

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

6.5

263

1868

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

6.5

149

931

E883A

ICD-9 Finland

Fall into hole or other opening in surface

1.7

6.5

134

815

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

6.5

139

855

SPAT1255

SPAT

Intravenous administration of medicine

1.6

6.5

158

1004

M54

ICD-10 Finland

Dorsalgia

1.4

6.5

255

1806

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

6.5

153

965

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.7

6.5

123

730

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.5

6.5

196

1312

S76

ICPC

Skin infection other

1.7

6.4

114

661

R03DA74

ATC

theophylline, combinations with psycholeptics; systemic

70.0

6.4

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

6.4

457

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

7.4

6.4

M35.7

ICD-10 Finland

Hypermobility syndrome

3.2

6.4

1410

FHL

Laparoscopy

2.3

6.3

224

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.0

6.3

345

WZC30

NOMESCO Finland

Teaching

1.4

6.3

297

2174

205

Kela drug reimbursment

Chronic hypertension

1.3

6.3

742

6195

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.3

6.3

235

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.9

6.3

496

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.8

6.3

100

561

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.0

6.3

400

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.4

6.3

198

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

11.0

6.3

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.7

6.3

123

736

4720C

ICD-9 Finland

Chronic pharyngitis and nasopharyngitis, Chronic rhinitis[RHINITIS VASOMOTORICA]

18.0

6.3

J01XB01

ATC

colistin; inhalant, parenteral

+∞

6.2

J43.8

ICD-10 Finland

Other emphysema

+∞

6.2

J43.2

ICD-10 Finland

Centrilobular emphysema

+∞

6.2

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.0

6.2

390

N03AF02

ATC

oxcarbazepine; oral

2.0

6.2

404

R01BA01

ATC

phenylpropanolamine; oral

1.7

6.2

121

724

D01

ICPC

Abdominal pain/cramps general

1.5

6.2

221

1531

M05BA07

ATC

risedronic acid; oral

2.0

6.2

377

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.0

6.2

341

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

7.0

6.2

A08

ICPC

Swelling

1.9

6.2

477

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

6.2

434

Z3231

NOMESCO Finland

Registered nurse

1.3

6.2

660

5448

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

4.1

6.2

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.4

6.2

202

C08CA02

ATC

felodipine; oral

1.5

6.2

226

1577

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

6.2

115

678

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.6

6.2

145

913

4239

FHL

Other measure in this category

6.3

6.2

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

6.1

499

A05

ICPC

Feeling ill

1.7

6.1

113

664

Z50.1

ICD-10 Finland

Other physical therapy

1.7

6.1

125

761

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

2.9

6.1

122

UDM02

NOMESCO Finland

Sinoscopy

2.4

6.1

197

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

6.0

100

571

A99

ICPC

Disease/condition unspecnature/site

1.5

6.0

178

1185

R83

ICPC

Respiratory infection other

1.3

6.0

544

4398

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

1.8

6.0

100

572

ZX120

NOMESCO Finland

Intravenous

1.5

6.0

220

1534

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

6.0

319

2385

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.6

6.0

139

873

H02AB09

ATC

hydrocortisone; systemic

2.2

6.0

249

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

2.6

6.0

155

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(4010399)

394

1304

3.25

93.58

1.5

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

362

1155

3.36

91.20

1.6

1.1

u/ml

280.9

213.7

0.72

340

1053

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

13.39

88.80

1.4

1.1

u/ml

1.4

0.1

2.28

(3023419) Bacteria identified in Sputum by Culture

116

154

7.73

82.39

4.3

1.7

—

(3013115) Eosinophils [#/volume] in Blood

1922

14127

1.72

57.71

7.2

5.9

e9/l

0.2

6.00

1729

12315

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

749

4273

1.93

51.87

2.3

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

369

1596

2.45

51.82

4.5

3.1

kpa

5.2

5.1

2.04

335

1458

(3006504) Eosinophils/100 leukocytes in Blood

1756

12858

1.67

51.33

7.5

5.9

3.0

2.8

1.86

1643

11937

(3022096) Basophils/100 leukocytes in Blood

1712

12458

1.67

51.22

7.5

6.0

0.6

0.7

0.80

1608

11577

(3019069) Monocytes/100 leukocytes in Blood

1760

12932

1.67

50.48

8.0

6.2

8.6

8.7

0.60

1659

12066

(3009343) pH of Capillary blood

362

1577

2.43

49.99

4.5

3.1

7.4

0.19

182

(3006315) Basophils [#/volume] in Blood

1840

13710

1.66

49.70

7.1

5.7

e9/l

0.0

1.61

1646

11792

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

214

722

3.08

48.59

3.5

2.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

1794

13349

1.64

48.20

7.7

6.0

27.1

28.0

2.74

1679

12383

(3001604) Monocytes [#/volume] in Blood

1826

13659

1.64

47.95

7.1

5.7

e9/l

0.6

10.51

1636

11745

(3019198) Lymphocytes [#/volume] in Blood

1874

14114

1.64

47.85

7.2

5.8

e9/l

1.9

0.02

1701

12355

(3018010) Neutrophils/100 leukocytes in Blood

1767

13140

1.64

47.28

7.4

5.8

57.9

57.2

1.63

1655

12237

(3023368) Bacteria identified in Blood by Culture

1131

7502

1.72

46.93

5.5

4.2

—

(4015189)

12.63

46.07

3.7

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

342

1521

2.37

44.95

4.5

3.1

mmol/l

1.9

1.6

0.83

259

1079

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

933

5947

1.75

44.23

1.9

1.8

mg/l

1.1

1.3

0.74

724

4493

(3000492) Spirometry study

440

2194

2.14

43.80

1.5

1.3

—

(42870588) Differential panel, method unspecified - Blood

1309

9164

1.65

43.58

6.9

5.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1140

7736

1.67

42.66

3.6

2.9

ng/l

1521.9

1529.4

0.02

992

6537

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1473

10777

1.59

40.08

4.7

3.4

ng/l

43.0

106.3

0.83

1044

7338

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1239

8727

1.62

39.33

2.9

2.5

u/l

52.5

58.4

5.67

1140

8036

(3022313) Gas panel - Capillary blood

270

1171

2.40

37.41

4.5

3.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2014

16030

1.54

36.53

9.8

9.0

e9/l

4.4

4.1

8.42

1807

13907

(3013707) Erythrocyte sedimentation rate by Westergren method

2496

20887

1.56

35.53

5.0

3.8

mm/h

13.3

11.6

5.80

2313

19298

(3007853) Bacteria identified in Skin by Aerobe culture

544

3169

1.83

34.08

2.1

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

258

1155

2.32

33.21

2.5

1.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2066

16748

1.50

32.88

5.8

4.6

mmol/l

6.8

0.81

1975

15622

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1835

14590

1.49

31.62

6.6

6.1

umol/l

10.4

12.0

8.68

1729

13795

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1745

13754

1.49

31.26

8.1

6.7

mmol/l

1.2

0.47

1490

11574

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

231

1030

2.32

29.98

4.9

3.3

mmol/l

25.1

24.8

0.89

213

937

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

235

1057

2.30

29.89

2.1

1.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1161

8517

1.52

28.87

2.4

2.1

u/l

195.9

242.6

0.94

1086

7993

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

175

4.29

28.61

4.0

3.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

599

3780

1.69

28.02

24.0

25.4

inr

1.3

0.06

112

547

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

166

677

2.52

26.24

1.4

1.3

—

(3032080) INR in Blood by Coagulation assay

1466

11455

1.45

25.88

10.0

9.1

inr

1.2

1.3

1.10

399

3220

(3042631) Mycobacterium sp identified in Specimen

266

3.44

25.42

3.5

2.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

239

3.57

25.14

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

794

5501

1.56

25.11

4.9

3.5

ng/l

581.6

485.1

0.14

599

4280

(3005719) IgG [Mass/volume] in Serum or Plasma

354

2006

1.84

23.87

3.1

2.6

g/l

10.3

10.7

1.26

330

1826

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

342

1922

1.86

23.67

1.8

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1547

12385

1.42

23.12

7.0

6.0

mmol/l

1.2

0.08

1391

11184

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1431

11310

1.42

22.95

2.5

2.2

nmol/l

76.7

76.8

0.07

1268

10146

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

294

1597

1.91

22.59

1.8

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1207

9279

1.44

22.44

3.6

3.2

u/l

30.2

36.0

2.60

1144

8791

(3042936) Bacteria identified in Isolate by Culture

590

3912

1.60

22.30

2.4

2.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

5.50

21.93

5.0

3.1

—

(3013512) EKG study

1081

8177

1.45

21.81

5.0

3.7

—

(3000494) Fungus identified in Specimen by Culture

487

3098

1.65

21.73

1.8

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

462

2901

1.67

21.68

2.1

1.6

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

143

596

2.45

21.61

4.1

2.8

mmol/l

24.7

24.5

0.26

115

519

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

462

2909

1.67

21.44

2.2

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

219

1096

2.06

21.27

1.6

1.5

u/ml

21.2

18.1

—

(3019225) pH of Specimen

445

2782

1.68

21.21

5.0

4.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2168

18551

1.39

21.10

5.9

4.3

e6/l

1777.6

1844.8

0.03

265

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

120

4.38

20.81

2.4

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

120

4.38

20.81

2.4

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

120

4.38

20.81

2.4

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

120

4.38

20.81

2.4

1.9

—

(3026008) Bacteria identified in Urine by Culture

1060

8056

1.44

20.63

3.8

3.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1001

7554

1.44

20.17

3.0

2.6

umol/l

4464.4

5340.1

0.27

871

6581

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

376

2278

1.72

20.10

3.8

2.8

ng/l

200.2

216.1

0.27

330

2059

(3004789) Transferrin [Mass/volume] in Serum or Plasma

595

4043

1.56

20.08

3.0

2.4

g/l

2.3

0.99

535

3739

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2510

22110

1.39

19.84

8.9

7.2

u/l

76.6

78.4

1.42

2370

20762

(3028026) IgM [Mass/volume] in Serum or Plasma

281

1570

1.85

19.76

1.8

1.9

g/l

1.2

1.4

0.66

256

1437

(3037467) Urinalysis macro (dipstick) panel - Urine

2268

19663

1.37

19.69

5.5

4.1

—

(3017732) Neutrophils [#/volume] in Blood

326

1918

1.76

19.31

2.9

2.8

e9/l

4.4

4.1

1.43

241

1502

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

154

701

2.25

19.06

1.6

1.3

iu/ml

14.4

9.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

146

650

2.30

19.05

1.2

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

5.40

18.99

1.1

u/ml

10.7

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

11.16

18.88

1.1

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

628

4379

1.52

18.72

3.0

2.4

umol/l

12.4

13.4

3.06

566

4050

(3028626) Oxygen [Partial pressure] in Capillary blood

126

530

2.42

18.70

3.3

2.6

kpa

8.1

8.2

0.26

113

485

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

555

3770

1.55

18.66

3.1

2.5

21.6

23.6

2.60

472

3227

(3000850) Epithelial cells [#/volume] in Urine

796

5885

1.44

17.56

3.4

2.6

e6/l

5.1

5.3

0.18

703

5160

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

925

7048

1.41

17.22

2.7

2.1

mg/l

3.2

2.9

2.08

789

5960

(3003396) Base excess in Arterial blood by calculation

452

2983

1.58

17.17

7.2

7.7

mmol/l

1.5

0.8

3.45

361

2292

(3007164) IgA [Mass/volume] in Serum or Plasma

711

5167

1.46

17.13

1.6

1.5

g/l

2.4

0.03

472

3216

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

389

2.59

17.00

1.2

1.1

u/ml

1.7

1.1

0.34

129

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

199

3.25

16.79

2.2

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

199

3.25

16.79

2.2

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

199

3.25

16.79

2.2

1.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

618

4387

1.49

16.75

1.3

iu/ml

32.4

0.00

194

1362

(3012095) Magnesium [Moles/volume] in Serum or Plasma

626

4463

1.48

16.59

4.1

3.3

mmol/l

0.8

0.63

571

4163

(3019309) Folate [Moles/volume] in Red Blood Cells

718

5260

1.45

16.52

1.9

1.8

nmol/l

1072.9

1151.2

1.39

523

3928

(3003888) Timothy IgE Ab [Units/volume] in Serum

360

2.62

16.47

1.1

u/ml

5.1

5.4

0.07

167

(3027135) IgG subclass 1 [Mass/volume] in Serum

222

3.10

16.46

1.5

1.3

g/l

6.6

7.0

0.48

149

(3024139) IgG subclass 3 [Mass/volume] in Serum

222

3.10

16.46

1.5

1.3

g/l

0.4

0.06

149

(3028192) IgG subclass 2 [Mass/volume] in Serum

222

3.10

16.46

1.5

1.3

g/l

2.9

3.0

0.25

148

(3024561) Albumin [Mass/volume] in Serum or Plasma

1475

12181

1.34

16.44

5.2

4.8

g/l

35.3

35.7

1.44

1360

11330

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

127

570

2.27

16.30

2.1

1.6

—

(4062490)

224

3.07

16.22

1.6

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

517

3561

1.52

16.17

1.4

1.3

titre

459.4

524.1

0.45

109

739

(40768797) Stomach Pathology biopsy report

526

3645

1.51

15.97

1.3

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

354

2.61

15.96

1.4

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

172

877

2.01

15.90

2.1

1.5

titre

151.4

352.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

317

2.69

15.66

1.1

1.0

u/ml

1.2

1.6

0.22

(3027801) Oxygen [Partial pressure] in Arterial blood

444

2981

1.55

15.58

7.3

7.7

kpa

11.2

12.8

10.75

419

2836

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

444

2983

1.55

15.53

7.3

7.7

kpa

5.2

5.0

1.98

420

2839

(3008401) Mugwort IgE Ab [Units/volume] in Serum

350

2.55

14.78

1.1

1.0

u/ml

1.1

1.5

0.23

122

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

254

2.83

14.67

2.5

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

160

3.34

14.61

1.3

1.1

—

(3016502) Oxygen saturation in Arterial blood

400

2667

1.56

14.44

7.4

8.2

94.5

95.9

2.95

383

2569

(3019060) Gas panel - Arterial blood

269

1627

1.70

14.40

5.1

5.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

579

4176

1.45

14.30

1.3

1.2

u/ml

21.2

12.1

0.55

209

1640

(3002582) Erythrocytes [#/volume] in Urine

1071

8587

1.34

14.04

4.1

3.1

e6/l

114.5

109.0

0.03

862

6567

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2231

19813

1.30

13.74

3.8

3.0

u/l

52.5

49.4

0.77

2082

18532

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

260

1586

1.69

13.49

1.7

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

821

6355

1.37

13.44

1.7

1.5

nmol/l

19.9

20.3

0.33

693

5433

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

520

3716

1.46

13.43

1.9

1.8

1.6

1.5

1.68

457

3296

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

234

2.81

13.30

2.6

1.7

—

(3021901) Oxygen saturation in Capillary blood

433

2.30

13.12

3.3

2.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1427

12008

1.30

13.02

3.4

2.7

ug/l

128.5

140.4

0.79

1312

11095

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

386

2.36

12.90

1.5

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

112

528

2.15

12.82

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

112

528

2.15

12.82

1.4

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

455

3198

1.48

12.76

4.3

4.4

u/l

233.3

248.0

1.80

423

3005

(3018095) Leukocytes [#/volume] in Urine

1211

9994

1.31

12.70

4.7

3.5

e6/l

108.0

106.0

0.03

921

7068

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

227

1357

1.71

12.70

7.8

10.4

mmol/l

24.7

24.1

1.88

204

1266

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.90

12.51

3.0

2.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

368

2485

1.53

12.51

2.6

2.3

ug/l

7.8

8.1

0.06

302

2162

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1370

11516

1.29

12.45

2.2

1.9

pmol/l

94.5

95.4

0.30

732

6024

(3020630) Protein [Mass/volume] in Serum or Plasma

340

2259

1.55

12.44

2.4

2.6

g/l

66.6

66.5

0.09

304

2050

(3011412) CD3 cells [#/volume] in Blood

260

2.64

12.43

2.6

2.5

e9/l

1.3

1.1

0.58

143

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

114

551

2.10

12.26

2.3

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3138

29404

1.37

12.17

21.5

13.1

mg/l

24.2

24.4

0.16

2690

22964

(3027945) Reticulocytes/100 erythrocytes in Blood

443

3128

1.47

12.12

3.4

2.5

1.7

1.8

0.15

380

2747

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2086

18527

1.28

12.07

3.4

2.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

342

2.40

12.05

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

300

2.50

12.02

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

240

1482

1.66

11.90

3.8

2.7

e6/l

0.4

0.3

0.27

235

1445

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.83

11.89

3.0

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.83

11.89

3.0

2.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

130

3.33

11.89

1.4

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

182

2.94

11.85

2.6

e6/l

657.7

561.4

0.46

144

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

761

5932

1.35

11.73

1.8

1.7

pmol/l

48039639.5

37146172.1

0.20

612

4940

(40760892) CBC W Ordered Manual Differential panel - Blood

774

6059

1.35

11.58

5.0

4.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

357

2447

1.51

11.30

2.1

nmol/l

338.5

379.2

3.82

322

2241

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

359

2.31

11.27

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

749

5864

1.34

11.15

1.3

1.2

u/ml

1.3

1.7

0.68

196

1563

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

150

831

1.84

10.91

1.4

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

197

2.77

10.85

1.9

2.2

10.9

14.0

0.77

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

479

3502

1.42

10.83

4.8

4.3

32.0

31.8

0.11

328

2373

(3003458) Phosphate [Moles/volume] in Serum or Plasma

492

3618

1.41

10.76

7.6

6.0

mmol/l

1.1

1.0

1.18

452

3363

(3015377) Calcium [Moles/volume] in Serum or Plasma

1127

9374

1.29

10.75

3.2

3.4

mmol/l

2.3

2.4

0.78

948

8174

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

185

1099

1.72

10.62

2.3

2.0

ug/l

3.6

2.7

0.18

154

971

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

100

489

2.07

10.48

1.9

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

173

2.86

10.47

2.7

2.6

e9/l

0.2

0.21

143

(3048689) Calprotectin [Mass/mass] in Stool

444

3229

1.42

10.33

2.4

ug/g

128.0

131.1

0.09

353

2575

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2368

21561

1.26

10.24

4.2

3.8

pmol/l

14.8

0.31

2166

19587

(3014133) Dog dander IgE Ab [Units/volume] in Serum

281

2.41

10.17

1.1

1.0

u/ml

6.3

1.4

1.49

(3021447) Carbon dioxide [Partial pressure] in Venous blood

363

2554

1.47

10.08

5.5

3.7

kpa

5.9

5.8

2.40

352

2479

(3022621) pH of Urine by Test strip

283

1894

1.53

10.02

3.5

3.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

310

2.31

9.86

1.3

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

1087

9080

1.27

9.86

3.0

2.4

—

(3002032) Base excess in Venous blood by calculation

360

2540

1.46

9.85

5.6

3.7

mmol/l

2.2

1.8

1.58

301

2031

(3014111) Lactate [Moles/volume] in Serum or Plasma

343

2413

1.46

9.52

7.2

7.3

mmol/l

1.5

1.4

0.37

326

2313

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

144

2.94

9.48

1.2

1.0

iu/ml

12.5

10.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1033

8609

1.27

9.48

4.3

4.0

mg/mmol

14.5

8.7

1.75

647

5547

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

164

975

1.71

9.42

2.5

2.4

ug/l

334.6

755.0

1.20

153

922

(3025941) Bacteria identified in Stool by Culture

237

1547

1.57

9.39

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

330

2.24

9.37

1.8

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

330

2.24

9.37

1.8

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

389

2.13

9.34

1.5

1.6

g/l

1.0

0.8

0.24

291

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

396

2.12

9.32

1.2

1.1

au/ml

8.4

9.9

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

262

2.39

9.29

1.0

u/ml

7.8

3.5

0.75

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

338

2.21

9.27

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

332

2.22

9.24

1.7

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

240

2.44

9.11

2.0

2.4

38.9

44.7

—

(3026782) Osmolality of Urine

701

5585

1.31

9.06

3.4

2.7

mosm/kgh2o

529.3

557.4

2.76

608

4752

(3009508) Creatinine [Moles/volume] in Urine

1044

8771

1.26

8.85

3.6

3.3

mmol/l

7.4

7.9

2.58

868

7370

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

122

679

1.82

8.81

2.3

2.0

mg/l

10.7

12.3

0.97

116

626

(3025468) Yersinia sp identified in Specimen by Organism specific culture

329

2.18

8.61

1.8

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

5.02

8.61

2.7

—

(3030467) Casts [#/volume] in Urine by Automated count

938

7811

1.27

8.52

3.9

3.0

e6/l

0.3

0.4

1.51

727

5868

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

344

2.14

8.49

1.1

g/l

1.5

0.10

314

(3012494) Peanut IgE Ab [Units/volume] in Serum

4.17

8.44

1.2

1.1

u/ml

2.9

2.2

0.11

(3017181) Myelocytes/100 leukocytes in Blood

312

2209

1.45

8.38

4.6

4.3

1.0

0.9

0.24

637

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

415

2.02

8.27

2.1

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

335

2.14

8.25

1.8

1.4

—

(3019977) pH of Arterial blood

123

2.94

8.22

2.3

2.6

7.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

5.35

8.20

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

5.35

8.20

1.1

100.8

94.9

0.24

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.69

8.16

1.6

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

113

634

1.81

7.98

1.6

1.7

e6/l

17597.9

15318.1

0.19

456

(3027273) Bicarbonate [Moles/volume] in Venous blood

202

1323

1.56

7.93

4.5

3.2

mmol/l

25.5

25.0

0.98

195

1283

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

376

2.04

7.82

1.9

2.0

titre

480.0

1094.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

208

2.42

7.81

2.6

2.5

e6/l

716.7

716.6

0.00

(3004588) Protein electrophoresis panel - Serum or Plasma

264

1836

1.47

7.80

2.3

2.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

283

1995

1.45

7.79

5.0

4.0

ng/l

113.5

93.2

1.75

240

1710

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

105

582

1.83

7.73

1.6

1.4

—

(36304419) Bacteria [Presence] in Urine

914

7666

1.25

7.70

3.7

3.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

192

2.47

7.64

2.1

—

(3012516) Albumin [Mass/volume] in Urine

966

8170

1.24

7.53

3.5

3.3

mg/l

327.7

347.9

0.05

625

5223

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

215

1445

1.52

7.51

2.3

2.4

—

(3004616) Nuclear Ab [Presence] in Serum

309

2.12

7.44

1.3

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

342

2518

1.39

7.39

10.1

7.5

mmol/l

10.1

9.9

0.14

329

2395

(3008757) Leukocyte morphology finding [Identifier] in Blood

284

2.17

7.37

4.7

4.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

172

1105

1.58

7.36

4.7

5.2

1.8

1.6

1.15

161

1033

(3002179) Metamyelocytes/100 leukocytes in Blood

282

2010

1.43

7.33

4.2

4.1

0.7

0.02

460

(3023520) Reticulocytes [#/volume] in Blood

317

2308

1.41

7.31

2.7

2.6

e9/l

70.5

68.4

0.53

254

1748

(3020874) Milk IgE Ab [Units/volume] in Serum

126

2.79

7.31

1.1

1.0

u/ml

0.6

0.5

0.07

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

163

1037

1.60

7.27

1.8

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

163

1038

1.60

7.24

1.8

2.3

g/l

6.9

7.3

1.52

121

765

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

3.83

7.24

2.0

1.4

ug/l

0.3

0.4

—

(3028433) Virus identified in Specimen by Culture

3.39

7.24

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

291

2091

1.42

7.23

4.6

4.3

0.2

0.1

0.42

579

(3025159) Blasts/100 leukocytes in Blood

275

1964

1.43

7.07

4.4

4.3

0.0

0.3

0.82

490

(3018677) aPTT in Platelet poor plasma by Coagulation assay

548

4361

1.30

7.04

2.6

2.2

30.3

29.9

0.55

529

4221

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

161

1036

1.58

6.86

1.9

2.3

g/l

3.6

3.8

0.84

112

729

(3000991) Gas panel - Venous blood

304

2223

1.40

6.85

9.7

8.7

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

4.10

6.80

2.3

1.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

548

1.79

6.76

2.1

g/l

129.4

130.3

0.13

402

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

828

6957

1.24

6.76

3.0

2.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

124

752

1.67

6.72

2.0

2.3

g/l

0.0

0.08

113

681

(3040151) Glucose [Moles/volume] in Capillary blood

296

2.08

6.66

7.5

5.6

mmol/l

7.2

7.3

0.13

244

(44806118)

263

2.15

6.65

2.0

1.4

—

(44790047)

263

2.15

6.65

2.0

1.4

—

(44790048)

263

2.15

6.65

2.0

1.4

—

(44790049)

263

2.15

6.65

2.0

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

152

974

1.58

6.61

1.9

2.4

g/l

3.1

0.05

112

749

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

352

1.98

6.58

7.0

6.6

mg/l

11.3

11.7

0.31

328

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

139

876

1.61

6.49

2.0

2.4

g/l

0.6

1.0

0.85

121

735

(40758558) Short blood count panel - Blood

834

7043

1.23

6.46

8.3

6.9

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

234

1651

1.44

6.45

8.6

6.9

mmol/l

25.0

24.2

2.07

219

1533

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

120

730

1.66

6.44

2.0

1.6

g/l

0.2

0.55

108

689

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2781

26292

1.21

6.26

5.1

4.4

mu/l

2.8

2.1

0.45

2557

24043

(3035350) Ketones [Presence] in Urine by Test strip

1530

13736

1.19

6.21

4.2

3.5

estimate

0.0

0.50

267

2484

(3022145) Colonoscopy Study observation

392

3035

1.32

6.14

1.3

—

(3018418) pH of Serum or Plasma

938

8059

1.22

6.10

4.7

4.0

7.4

0.67

160

1544

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

146

946

1.56

6.08

5.6

3.4

u/ml

0.3

0.19

546

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

253

2.11

6.07

1.0

u/ml

1.2

0.4

0.45

(40768804) Tissue Pathology biopsy report

1276

11294

1.19

6.04

2.2

2.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

523

1.76

6.03

1.5

1.6

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.88

5.98

1.5

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.88

5.98

1.5

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

117

722

1.64

5.97

1.2

1.1

—

(1616796) Gas panel - Central venous blood

547

1.74

5.97

3.0

3.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

551

4478

1.27

5.96

3.4

2.8

e6/l

2.9

2.4

0.62

322

2419

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2905

27625

1.21

5.93

17.2

12.4

ml/min/173m2

81.1

81.8

0.90

2466

22813

(3021601) Nitrite [Presence] in Urine by Test strip

1528

13758

1.18

5.90

5.9

4.8

estimate

0.0

0.50

278

2547

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2828

26829

1.20

5.90

6.6

5.5

mmol/mol

40.7

39.7

4.29

2617

24865

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

132

842

1.59

5.89

2.5

3.6

mg/l

35.3

54.4

1.16

109

681

(3007930) Methemoglobin/Hemoglobin.total in Blood

164

1099

1.51

5.88

4.8

5.2

0.9

0.35

153

1029

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

121

758

1.62

5.82

2.0

1.6

g/l

1.2

0.06

111

717

(3041096) Erythrocytes [Presence] in Urine by Automated

884

7585

1.21

5.79

4.1

3.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

132

846

1.58

5.78

2.5

3.6

mg/l

59.8

64.1

0.10

107

685

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

128

818

1.58

5.68

2.5

3.6

ratio

4.5

2.5

0.28

(3002173) Hemoglobin [Mass/volume] in Arterial blood

328

2506

1.34

5.64

8.6

8.5

g/l

122.2

121.4

0.29

316

2415

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

115

719

1.62

5.59

1.4

—

(40768443) Skin Pathology biopsy report

172

1179

1.48

5.54

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

164

1114

1.49

5.53

2.2

1.9

u/l

37.9

39.6

0.54

151

976

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

126

809

1.58

5.50

2.0

2.2

g/l

38.6

37.8

0.69

106

678

(3009261) Glucose [Presence] in Urine by Test strip

1538

13915

1.18

5.49

4.3

3.6

estimate

0.0

0.28

257

2446

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

585

4834

1.25

5.47

1.6

1.5

—

(3000330) Specific gravity of Urine by Test strip

202

1432

1.43

5.47

4.3

3.2

—

(3014271) Vancomycin [Susceptibility]

147

2.39

5.46

3.8

2.7

—

(3019150) Specific gravity of Urine by Refractometry

715

6046

1.22

5.39

4.4

4.0

kg/l

1.0

0.64

139

897

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

173

2.27

5.38

2.1

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

273

1.99

5.35

3.4

3.8

59.9

56.2

0.46

175

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

300

2280

1.34

5.35

3.5

2.5

ml/min/173m2

66.6

67.3

0.09

110

900

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

111

697

1.61

5.32

2.0

2.3

g/l

0.0

0.00

101

640

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

112

707

1.60

5.26

2.0

2.3

g/l

0.0

0.00

101

641

(3047181) Lactate [Moles/volume] in Blood

127

828

1.55

5.20

5.9

6.1

mmol/l

1.4

1.3

0.32

115

720

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.65

5.20

1.5

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

182

1282

1.44

5.12

1.8

1.6

g/l

1.4

1.5

1.79

150

1076

(4024509)

257

2.00

5.12

1.6

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

191

1359

1.43

5.09

1.1

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

4.20

5.08

1.1

1.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

144

970

1.50

5.08

1.9

2.3

g/l

9.8

10.4

1.02

121

803

(3014576) Chloride [Moles/volume] in Serum or Plasma

433

3484

1.27

5.08

8.1

7.0

mmol/l

104.1

104.5

1.03

412

3417

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

536

1.68

5.05

1.2

—

9.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1207

10763

1.18

5.04

4.4

3.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

573

4770

1.24

5.00

3.2

2.6

e6/l

1.4

1.2

0.20

345

2687

(3052851) Hemolysis interference index of Serum or Plasma

126

830

1.54

4.95

4.0

3.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

456

1.73

4.94

1.2

1.3

u/l

73.4

35.5

0.65

392

(4146454)

303

1.89

4.92

2.5

2.7

—

(40761535) Cells panel - Urine sediment

296

2280

1.32

4.84

3.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

474

1.70

4.83

1.1

iu/ml

4.8

1264.3

0.55

106

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.00

4.82

1.4

1.2

—

(3037121) Protein [Mass/volume] in Urine

147

1009

1.47

4.76

3.5

3.0

g/l

0.4

0.09

424

(3000060) B lymphocytes [#/volume] in Blood

2.89

4.75

1.4

2.0

e6/l

142.5

171.5

0.25

(3020191) Ethanol [Moles/volume] in Serum or Plasma

244

1.98

4.73

2.2

1.4

promille

1.6

1.2

0.86

185

(3014599) Egg white IgE Ab [Units/volume] in Serum

126

2.39

4.72

1.1

1.0

u/ml

0.2

0.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

177

2.16

4.71

2.4

2.9

34.5

37.5

0.33

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.79

4.71

2.0

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.79

4.71

2.0

2.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

111

721

1.56

4.66

1.3

1.2

u/ml

32.0

47.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

397

1.75

4.64

1.7

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

119

786

1.53

4.64

1.5

1.4

ug/g

218.6

280.1

3.29

437

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

14.02

4.57

1.3

1.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

276

2123

1.32

4.57

5.1

3.1

kpa

4.9

4.6

0.80

265

2054

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.65

4.48

3.7

3.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

104

674

1.56

4.43

1.3

1.2

u/ml

13.6

7.0

0.29

106

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

401

3251

1.26

4.43

3.1

2.8

umol/l

6.2

8.7

2.49

333

2828

(3021788) Differential panel - Synovial fluid

480

1.66

4.38

1.5

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

436

1.69

4.32

4.5

3.8

1.2

1.4

0.30

334

(3027923) C peptide [Moles/volume] in Serum or Plasma

151

2.20

4.30

2.1

1.3

nmol/l

1.2

0.03

114

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

586

1.58

4.24

9.7

5.5

iu/ml

618.2

1005.1

0.33

(3051387) C reactive protein [Mass/volume] in Capillary blood

100

650

1.55

4.22

5.5

3.2

mg/l

22.6

26.9

0.75

409

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

330

2631

1.28

4.19

2.4

2.2

g/l

0.2

0.12

314

2444

(40760888) Immunoglobulin light chains.free panel - Serum

636

1.55

4.17

2.6

3.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

109

2.39

4.14

2.2

2.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

535

1.60

4.12

1.2

u/ml

2.0

3.9

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

102

670

1.54

4.12

1.3

1.2

u/ml

2.7

3.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

119

808

1.49

4.11

2.0

1.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1467

13437

1.15

4.10

4.7

4.0

—

(3045414) Leukocytes [Presence] in Urine

170

1236

1.39

4.07

2.1

1.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

433

3577

1.24

4.05

8.2

6.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.46

4.04

1.5

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

591

5040

1.20

4.03

1.9

1.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3118

30132

1.18

4.01

22.8

15.2

mmol/l

139.5

139.7

2.15

3063

29309

(3003327) Ova and parasites identified in Stool by Light microscopy

124

854

1.47

4.00

1.8

1.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

244

1885

1.31

3.95

2.5

2.4

au/ml

12.4

24.1

—

116

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

125

2.25

3.89

1.3

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

257

1.84

3.80

1.5

1.3

e6/l

150221.5

89666.9

0.21

181

(3010421) pH of Blood

106

716

1.49

3.79

3.0

3.5

7.4

0.20

593

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

331

1.73

3.78

1.4

1.5

—

(3016228) CD19 cells/100 cells in Blood

114

2.29

3.77

2.3

2.1

10.4

9.3

0.11

109

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

282

1.78

3.67

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

210

1.91

3.67

1.2

1.3

mmol/l

9.2

12.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.86

3.62

1.1

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3122

30244

1.17

3.57

22.9

15.3

mmol/l

4.0

0.17

3064

29368

(3014051) Protein [Presence] in Urine by Test strip

628

1.51

3.56

2.5

2.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

189

1432

1.34

3.53

10.6

10.9

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

120

844

1.44

3.51

1.7

1.6

iu/ml

0.4

0.2

0.29

173

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

288

1.75

3.44

1.8

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

160

2.01

3.39

1.5

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

133

2.11

3.39

1.8

2.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

346

2853

1.23

3.33

3.3

4.2

ug/l

32.7

19.3

0.24

289

2319

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

453

1.58

3.32

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

134

972

1.39

3.32

1.3

1.2

u/ml

0.2

0.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

162

1.98

3.28

1.5

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

326

2675

1.24

3.28

2.3

2.2

nmol/l

13.0

13.3

0.33

294

2425

(3023183) Ammonium ion [Moles/volume] in Plasma

608

1.49

3.26

2.5

3.1

umol/l

32.1

37.2

1.19

514

(1761482) Bacteria [#/volume] in Urine by Culture

108

757

1.44

3.25

4.9

4.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

123

2.12

3.19

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

123

2.12

3.19

1.6

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.37

3.18

1.1

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

549

1.50

3.12

3.3

3.0

nmol/l

0.9

0.8

0.28

414

(3012501) Base excess in Blood by calculation

607

1.48

3.10

3.1

3.6

mmol/l

2.6

2.4

0.13

381

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

208

1630

1.29

3.09

3.0

3.4

pmol/l

4.4

4.5

0.29

184

1430

(40757373) Influenza virus identified in Isolate

2.68

3.05

2.0

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

174

1.90

3.04

1.5

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

2.89

3.02

1.6

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2920

28246

1.14

3.02

5.0

4.3

mmol/l

6.1

6.0

3.76

2668

25750

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

147

1.98

2.99

1.3

—

218.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

324

1.64

2.98

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

364

1.60

2.95

2.7

2.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

222

1767

1.27

2.94

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

648

1.45

2.92

1.9

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

113

816

1.40

2.92

3.8

2.8

g/l

3.9

3.5

1.01

107

776

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

170

1309

1.31

2.90

6.6

4.1

mmol/l

24.4

24.0

0.67

159

1181

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

170

1.89

2.90

1.5

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

136

1014

1.35

2.89

1.6

1.7

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

100

712

1.42

2.81

1.2

1.4

mg/l

452.8

525.7

1.33

672

(3009466) Valproate [Moles/volume] in Serum or Plasma

409

1.55

2.79

6.9

5.1

umol/l

354.2

370.6

0.42

350

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.92

2.77

1.0

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

581

1.46

2.76

1.6

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

681

1.42

2.76

2.1

2.2

ug/min

146.6

94.6

0.35

423

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.01

2.72

1.1

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

517

1.48

2.72

1.3

1.2

u/ml

39.5

43.6

0.08

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.71

8.3

5.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

132

1.98

2.69

2.8

2.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

214

1716

1.26

2.69

5.1

3.2

g/l

128.2

129.5

0.36

209

1675

(3042733) HLA Ab [Presence] in Serum

105

2.10

2.68

3.4

4.6

—

(3039000) Anion gap in Blood

586

1.44

2.65

6.3

7.3

mmol/l

11.5

11.4

0.02

523

(3018572) Chloride [Moles/volume] in Blood

587

1.44

2.63

6.3

7.3

mmol/l

104.5

105.4

0.92

524

(3044941) Cell count panel - Synovial fluid

432

1.51

2.61

1.5

1.4

—

(3006270) Folate [Moles/volume] in Blood

251

1.68

2.61

1.2

nmol/l

387.6

357.9

0.35

219

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

320

2690

1.21

2.59

2.6

2.4

u/l

31.9

56.8

0.79

274

2324

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

267

1.66

2.59

3.2

2.6

—

(3051651) Icteric interference index of Serum or Plasma

170

1.83

2.58

3.9

3.5

—

(3017569) Oxygen content in Arterial blood

107

2.06

2.56

1.9

2.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

115

853

1.36

2.56

1.3

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.15

2.55

1.6

2.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.15

2.55

1.6

1.4

—

(3036603) Volume of Urine

171

1.82

2.54

1.5

1546.5

1948.5

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

363

1.55

2.53

1.4

1.3

nmol/l

0.6

0.00

351

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

308

1.60

2.52

1.4

1.6

67.1

59.0

0.77

193

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.16

2.50

1.2

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

255

1.65

2.48

1.2

1.1

—

(36660697) Celiac disease serology panel - Serum

256

2115

1.23

2.48

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

123

1.96

2.45

1.1

u/l

77.3

84.5

0.15

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

123

1.96

2.45

1.1

u/l

26.8

28.9

0.05

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

164

1292

1.28

2.41

4.5

2.7

0.7

0.6

1.17

159

1234

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.01

2.40

1.3

mg/l

1.7

4.0

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.01

2.40

1.3

mg/l

0.9

1.8

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

5.01

2.40

1.3

mg/l

1.4

3.8

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

5.01

2.40

1.3

mg/l

1.4

3.6

—

(44813793)

131

1.91

2.40

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.64

2.36

7.4

5.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

111

1.99

2.35

2.4

2.1

umol/l

139.5

140.8

0.01

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

501

1.45

2.34

2.0

1.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

589

1.40

2.26

3.4

2.0

nmol/l

1.0

0.8

0.67

496

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

209

1710

1.23

2.24

9.9

9.5

1.5

1.3

1.61

209

1700

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

407

1.48

2.24

1.4

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

328

1.53

2.18

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

568

1.40

2.17

1.4

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

807

7368

1.12

2.17

4.3

3.9

estimate

0.0

0.05

254

2414

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

265

1.59

2.17

1.4

1.2

u/l

55.0

57.3

0.11

183

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

107

809

1.33

2.16

1.8

1.7

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

536

1.41

2.14

3.0

3.7

60.8

57.0

1.93

536

(3051611) Lipemic interference index of Serum or Plasma

282

1.57

2.13

3.6

3.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

207

1703

1.23

2.13

10.1

9.6

0.7

0.16

207

1689

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

630

1.37

2.13

1.2

1.3

mmol/l

3.8

0.01

583

(3006653) Thiamine [Moles/volume] in Blood

130

1.85

2.12

1.3

1.2

nmol/l

129.4

136.4

0.32

130

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2867

27892

1.11

2.10

4.4

3.8

mmol/l

1.4

1.3

3.43

2627

25650

(3032773) Endomysium IgG Ab [Titer] in Serum

213

1.65

2.09

1.2

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

316

1.53

2.08

1.5

1.3

nmol/l

—

(3049717) Cytology report of Urine Cyto stain

137

1078

1.28

2.08

2.7

2.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.00

2.07

2.2

2.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.91

2.07

1.2

1.3

—

581.2

—

(3008037) Lactate [Moles/volume] in Venous blood

651

1.36

2.06

4.1

2.9

mmol/l

1.5

1.7

1.19

628

(3034274) Bile acid [Moles/volume] in Serum --fasting

277

1.56

2.05

1.9

2.1

umol/l

5.1

9.2

1.04

198

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.50

2.05

1.0

—

(3044927) Protein electrophoresis panel - Urine

285

1.55

2.05

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.33

2.04

1.0

1.1

umol/24h

0.8

0.7

—

(3024263) Appearance of Synovial fluid

148

1.76

1.98

1.8

1.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.28

1.97

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

272

1.55

1.97

1.5

1.6

—

(3011985) Renin [Units/volume] in Plasma

353

1.48

1.97

1.4

mu/l

90.8

52.5

0.44

309

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

104

796

1.31

1.96

1.2

1.3

miu/ml

178.1

209.4

0.49

340

(3024471) HLA-A [Type]

105

1.91

1.95

1.1

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.73

1.93

1.1

1.0

—

(40768446) Kidney Pathology biopsy report

113

1.86

1.91

1.3

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

128

1.80

1.89

1.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

140

0.36

1.88

1.4

1.5

—

(3021589) Normoblasts [#/volume] in Blood

1317

12411

1.09

1.87

11.5

9.1

e9/l

0.0

0.65

1100

10143

(21494890) Protein electrophoresis panel - 24 hour Urine

276

1.53

1.86

1.6

2.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

715

1.32

1.86

1.1

u/ml

1.0

5.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

467

1.40

1.84

1.2

1.1

—

(3025130) Human papilloma virus identified in Specimen

277

1.52

1.84

1.8

—

(3032057) Clostridioides difficile [Presence] in Stool

2.21

1.84

1.9

1.8

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.17

1.82

2.2

1.9

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.17

1.82

6.0

5.0

umol/l

262.4

495.4

—

(3051593) INR in Capillary blood by Coagulation assay

130

1.77

1.81

5.5

12.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

111

868

1.29

1.81

2.8

2.4

93.2

90.5

0.71

105

817

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

191

1.63

1.80

1.1

1.0

ng/l

647.6

729.0

0.68

118

(3001729) Color of Synovial fluid

3.05

1.80

2.1

1.6

—

(3045716) Anion gap in Serum or Plasma

123

1.79

2.0

2.6

mmol/l

8.2

10.1

0.51

(3017143) Hepatitis C virus Ab [Presence] in Serum

380

3352

1.15

1.78

1.9

1.6

—

(3045142) Bone marrow Pathology biopsy report

320

1.47

1.78

1.2

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

564

5105

1.12

1.77

2.9

3.1

mmol/l

2.5

2.4

0.24

488

4465

(3035637) Corticotropin [Mass/volume] in Plasma

296

1.49

1.77

1.3

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

154

1.69

1.75

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

105

819

1.29

1.75

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

139

1.73

1.75

1.7

u/field

2.8

2.3

0.11

101

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

133

1069

1.25

1.74

1.8

1.9

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

193

1.61

1.74

1.1

1.0

ng/l

370.8

310.0

0.32

123

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

193

1.61

1.74

1.1

1.0

ng/l

57.0

42.9

0.47

119

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

104

811

1.29

1.74

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

104

813

1.29

1.71

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

629

1.33

1.71

1.3

1.5

e6/l

511.8

839.6

0.34

512

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.06

1.70

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.06

1.70

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.91

1.69

2.5

2.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

535

1.35

1.69

1.4

1.2

u/ml

233.3

264.6

0.48

342

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

111

1.81

1.68

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

610

0.68

1.67

1.2

1.5

—

(3002619) Bacteria identified in Specimen by Culture

2.38

1.67

1.1

1.2

—

(21494755) Public health laboratory ask at order entry panel

274

3152

0.86

1.66

1.4

—

(3036489) Thrombin time

131

1058

1.25

1.66

2.6

2.2

22.2

21.3

0.42

116

931

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.16

1.66

1.8

3.2

—

(3038515) Glucose [Moles/volume] in Venous blood

615

1.32

1.66

4.4

2.9

mmol/l

7.1

7.7

1.66

597

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.58

1.65

1.1

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

469

1.37

1.65

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method

748

1.29

1.63

6.3

3.8

—

(40762814) Titanium [Mass/volume] in Blood

2.25

1.63

2.3

2.2

ug/l

3.7

5.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

150

1.67

1.63

1.1

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

237

1.52

1.62

1.6

2.0

—

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

336

1.43

1.61

1.3

1.4

pmol/l

264.9

261.8

0.03

259

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.50

1.59

1.3

1.2

—

(3017509) Phencyclidine [Presence] in Urine

2.50

1.59

1.0

1.8

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

167

1.62

1.58

1.3

1.4

u/ml

23.3

19.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

629

1.31

1.58

1.2

1.5

e6/l

6.2

24.8

1.13

481

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

137

1.68

1.55

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

137

1.68

1.55

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

168

1.61

1.54

1.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

554

1.32

1.52

2.6

2.2

16.0

16.5

0.50

255

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.34

1.52

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

146

1207

1.22

1.51

2.3

1.9

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.60

1.51

2.4

2.5

—

(3020393) Adenovirus Ag [Presence] in Stool

2.60

1.51

1.3

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

358

1.40

1.50

1.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

572

0.70

1.50

1.2

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

154

1.63

1.49

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2971

29106

1.09

1.49

4.8

4.2

mmol/l

4.6

2.68

2754

27054

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

571

0.70

1.48

1.2

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.95

1.48

1.1

—

(40761511) CBC panel - Blood by Automated count

3134

30778

1.10

1.48

18.5

12.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

139

1.66

1.48

1.5

1.1

iu/ml

3.4

4.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

479

1.34

1.47

1.7

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

570

0.70

1.47

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

570

0.70

1.47

1.2

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.81

1.47

6.1

2.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

102

814

1.26

1.46

5.9

4.1

mmol/l

3.9

0.24

766

(3043238) Trisomy 21 risk [Likelihood] in Fetus

499

0.68

1.46

1.3

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.23

1.46

1.8

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.37

1.45

1.9

1.5

ng/l

88.8

132.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.50

1.45

1.6

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

252

1.47

1.45

1.4

mmol/l

6.6

6.5

0.13

234

(3037756) Immunofixation for Serum or Plasma

560

1.31

1.43

1.9

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

237

1.48

1.41

1.1

mg/l

287.9

285.1

0.10

217

(3010375) cycloSPORINE [Mass/volume] in Blood

141

1.63

1.41

28.0

22.6

ug/l

95.6

113.8

0.69

115

(3024932) HLA-DR beta [Type]

103

1.75

1.40

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2947

28886

1.09

1.39

4.8

4.2

mmol/l

1.4

6.39

2718

26712

(4306422)

432

1.35

1.39

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.42

1.39

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.08

1.38

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

491

0.69

1.36

1.2

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

127

1.66

1.36

1.1

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

127

1.66

1.36

1.1

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

374

1.37

1.35

1.0

1.1

u/ml

1.3

2.4

2.08

185

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.83

1.35

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

504

1.31

1.35

3.8

3.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

112

1.70

1.35

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1.76

1.34

1.6

2.0

mg/l

9.7

9.6

0.01

(3005033) Fetal Nuchal fold Thickness US

489

0.69

1.34

1.2

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

333

1.39

1.32

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

325

1.39

1.31

1.0

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

428

1.34

1.31

1.6

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

800

1.24

1.31

3.6

3.4

mg/l

1.6

1.5

0.38

736

(3005570) Glucose [Moles/volume] in Urine

292

1.41

1.30

1.7

1.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

292

1.41

1.30

1.0

1.2

—

(3035880) pH of Pleural fluid

145

1.59

1.28

1.2

1.3

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.78

1.28

1.0

1.1

iu/ml

—

9.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.89

1.28

1.6

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.94

1.27

1.0

—

(3003181) Sodium [Moles/volume] in Urine

466

1.31

1.26

1.5

1.3

mmol/l

59.7

63.7

0.38

373

(3048879) Bone marrow aspiration report

1.82

1.25

1.6

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

108

889

1.22

3.0

2.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

251

2218

1.14

1.22

1.5

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.04

1.22

1.7

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.04

1.22

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

303

2711

1.13

1.21

2.1

1.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

648

1.26

1.19

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.83

1.19

1.2

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.31

1.18

1.2

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

533

1.28

1.18

1.7

1.4

u/ml

108.9

121.8

0.51

101

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

489

1.29

1.18

3.6

3.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1.70

1.17

3.1

2.9

umol/l

25.0

28.9

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

141

1.56

1.17

1.5

1.7

mmol/l

7.4

7.9

0.37

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

166

1.51

1.14

1.4

1.6

u/l

8.6

6.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

106

878

1.21

1.14

3.3

2.3

u/l

703.8

5079.1

4.46

350

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

249

1.41

1.14

2.3

2.2

u/field

0.9

2.1

1.56

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

150

1.54

1.14

1.0

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3197

31517

1.08

1.12

12.5

9.7

u/l

27.7

27.6

0.16

3109

30365

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

267

1.39

1.12

1.1

1.2

—

(3025577) Chromium [Mass/volume] in Blood

167

1.50

1.12

2.1

2.0

ug/l

2.5

2.0

0.33

141

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

327

2957

1.12

1.11

3.6

3.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.26

1.10

1.1

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1143

10910

1.07

1.09

4.4

4.5

ug/l

3.2

3.3

0.04

1035

9858

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.95

1.08

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

144

1.53

1.08

1.0

1.1

—

(3002256) Pathology report gross observation

396

3625

1.10

1.07

1.3

—

(3045424) Erythrocytes [Presence] in Urine

463

1.28

1.04

1.4

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

679

6375

1.08

1.04

3.8

3.5

—

(3024869) Neuronal Ab [Presence] in Serum

1.96

1.03

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.84

1.02

2.5

1.1

umol/l

18.6

16.5

0.56

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.74

1.02

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.89

1.01

2.2

2.0

umol/l

15.7

16.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.77

1.00

2.0

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.00

1.00

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

139

1.51

1.00

2.2

3.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

155

1347

1.16

1.00

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

343

1.32

0.99

1.2

1.3

u/l

16.5

23.8

1.22

284

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

257

1.37

0.98

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.18

0.98

1.0

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.18

0.98

4.6

2.3

mg/l

1.4

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

249

1.37

0.97

1.6

1.5

27.0

28.0

0.06

154

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

249

1.37

0.97

1.2

1.6

—

(3028300) Cannabinoids [Presence] in Urine

134

1155

1.17

0.96

2.8

2.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.85

0.96

2.8

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3009

29645

1.07

0.96

5.1

4.6

mmol/l

2.7

2.8

1.60

2775

27370

(44816559) Phosphatidylethanol [Mass/volume] in Blood

577

1.23

0.96

1.8

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.89

0.94

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

183

1.42

0.93

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

183

1.42

0.93

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

183

1.42

0.93

1.3

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.22

0.93

2.5

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.73

0.92

2.0

3.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

142

1.48

0.92

1.2

1.1

—

9.9

—

(3051101) Glucose [Moles/volume] in Cord blood

1.82

0.92

3.8

6.9

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.14

0.91

1.8

1.2

—

(3027008) Opiates [Presence] in Urine

133

1153

1.16

0.90

2.7

2.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

118

1.53

0.90

3.5

3.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.07

0.89

1.2

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

332

1.30

0.89

1.5

e6/l

1945.4

1614.3

0.29

243

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

185

1.41

0.89

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

185

1.41

0.89

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

185

1.41

0.89

1.3

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

583

1.22

0.89

3.5

3.6

u/ml

284.4

939.6

0.65

540

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.69

0.88

1.3

ug/l

348.1

554.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

342

1.29

0.87

2.1

mg/l

22.9

23.2

0.02

(3013005) Retinol [Moles/volume] in Serum or Plasma

103

1.56

0.87

3.7

1.4

umol/l

1.9

2.0

0.32

(3007566) Smooth muscle Ab [Titer] in Serum

778

1.19

0.86

1.2

1.3

titre

111.3

84.8

—

(3016879) Cocaine [Presence] in Urine

123

1066

1.16

0.85

2.9

2.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

153

1.44

0.85

1.0

1.1

u/l

1.0

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

145

1.45

0.84

1.5

1.3

—

(4212803)

1.94

0.84

1.2

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

248

1.33

0.83

3.0

3.3

mg/l

161.6

36.9

0.81

192

(3038177) Helicobacter pylori Ab [Presence] in Serum

470

1.24

0.83

1.2

—

(3008898) HLA-B27 [Presence]

103

883

1.17

0.82

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

114

0.53

0.82

6.0

6.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

114

0.53

0.82

3.0

3.1

—

(3012441) Differential panel - Pleural fluid

284

1.31

0.81

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

247

2246

1.11

0.81

3.2

3.8

mmol/l

1.2

1.00

217

1952

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

673

1.19

0.80

1.5

—

(3003338) MCHC [Mass/volume]

2508

25515

0.95

0.80

24.8

16.8

g/l

332.4

333.1

3.69

2491

25267

(3000764) Benzodiazepines [Presence] in Urine

131

1148

1.15

0.79

2.8

2.5

—

(3020491) Glucose [Moles/volume] in Blood

224

1.34

0.79

1.3

2.1

mmol/l

8.0

6.7

0.76

149

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1021

0.85

0.79

1.4

1.5

—

(3003694) ABO and Rh group [Type] in Blood

778

8155

0.94

0.79

1.4

—

(3024928) Oxygen saturation in Venous blood

610

1.20

0.79

6.9

3.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.82

0.79

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

574

1.21

0.78

1.2

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

357

1.26

0.78

1.3

mmol/l

7.2

0.01

263

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.53

0.78

3.1

1.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

199

1.36

0.78

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.76

0.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.76

0.0

1.0

—

(1002224) Polysomnography panel

141

1247

1.14

0.76

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

770

1.17

0.76

1.2

—

1313.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.60

0.74

1.2

1.1

—

(3025315) Body weight

2.08

0.74

3.8

3.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

327

3032

1.09

0.73

2.3

2.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.00

0.72

1.0

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.61

0.72

1.1

1.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

142

1.41

0.72

1.1

1.2

—

68.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

109

1.47

0.70

1.1

ng/l

1275.6

287.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

109

1.47

0.70

1.1

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.92

0.70

2.0

2.4

u/field

0.6

0.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

203

1.33

0.70

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

101

1.49

0.70

1.2

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.71

0.70

12.3

mmol/l

5.7

—

(3000012) Reticulocyte production index

144

0.62

0.69

1.1

1.6

—

(3020891) Body temperature

121

1068

1.14

0.69

5.7

4.5

—

(3001556) Androgen free Index in Serum or Plasma

1.85

0.68

1.0

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

575

1.19

0.67

1.3

1.2

—

(3027944) Amphetamines [Presence] in Urine

127

1127

1.13

0.67

1.9

2.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

116

1024

1.14

0.67

2.1

3.4

u/ml

2218.5

4423.1

0.29

885

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

136

1.40

0.66

1.4

mmol/l

5.7

6.0

0.52

131

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

189

1719

1.10

0.66

1.2

iu/ml

129.4

151.7

0.35

617

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.57

0.65

7.3

5.5

67.8

70.7

—

(40768806) Pleura Pathology biopsy report

286

1.26

0.65

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

268

2892

0.92

0.65

1.8

1.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.72

0.64

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

112

1.43

0.63

3.9

1.3

umol/l

26.4

28.7

0.39

105

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

181

1.33

0.63

1.6

1.7

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.55

0.62

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.59

0.61

1.3

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

766

7358

1.05

0.60

5.0

3.9

89.6

88.9

0.32

742

7182

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.57

0.60

1.3

1.0

—

(4198724)

148

1.35

0.59

1.7

3.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.59

0.0

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

799

1.14

0.59

1.4

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

810

0.86

0.59

1.5

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

175

1914

0.91

0.59

1.5

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

166

1.33

0.58

9.6

6.9

u/ml

43.5

14885.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

246

1.26

0.58

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

632

1.16

0.57

1.6

1.9

iu/l

912.9

4.8

0.48

223

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.67

0.56

1.2

—

(3004451) EKG impression Narrative

141

1.35

0.56

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

171

0.70

0.54

5.7

7.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.58

0.54

1.0

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.50

0.54

1.4

2.6

—

(3013637) Mi-2 Ab [Presence] in Serum

1.45

0.53

1.2

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.45

0.53

1.2

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.45

0.53

1.2

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.45

0.53

1.2

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

178

1.29

0.52

1.3

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

196

1.28

0.52

1.4

2.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

196

1.28

0.52

1.2

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

767

7403

1.04

0.51

1.6

mmol/l

1.5

1.4

1.04

646

6243

(3019897) Erythrocyte distribution width [Ratio] by Automated count

380

0.81

0.51

3.6

2.3

13.3

13.1

0.33

375

(40768793) Breast Pathology biopsy report

564

0.85

0.51

1.6

1.3

—

(3047189) Immunofixation for 24 hour Urine

135

1.33

0.51

1.5

1.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

197

1.27

0.51

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

197

1.27

0.51

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

2396

24275

0.97

0.50

23.3

16.1

13.9

13.6

6.09

2359

23684

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

408

1.18

0.49

1.1

112.6

113.9

0.08

375

(3004775) Volume in Urine collected for unspecified duration

216

1.25

0.49

2.3

2.0

637.0

610.3

0.15

144

(3019832) Treponema pallidum Ab [Presence] in Serum

266

2497

1.07

0.48

1.7

—

(40758292) HTLV I+II Ab panel - Serum

1.52

0.48

1.4

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

165

1521

1.09

0.48

2.4

2.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

299

1.21

0.47

1.6

1.4

e6/l

49019.5

78690.6

0.35

184

(40768800) Prostate Pathology biopsy report

602

0.86

0.47

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.41

0.46

1.2

1.1

87.9

101.1

0.46

(3009214) Lutropin [Units/volume] in Serum or Plasma

816

1.12

0.46

1.5

1.4

u/l

8.2

8.7

0.15

670

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.62

0.45

1.6

1.3

ug/l

8.8

9.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

310

1.20

0.45

2.5

—

(3029075) Extractable nuclear Ab panel - Serum

1.43

0.45

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

198

0.76

0.45

1.8

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

210

1.24

0.45

1.2

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.40

0.44

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

672

0.88

0.44

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

293

1.20

0.44

1.3

1.2

—

(3015183) Erythrocyte sedimentation rate

151

0.73

0.42

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

113

1.33

0.42

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

131

1.30

0.42

1.3

1.1

—

(21494434) Karyotype in Bone marrow

249

1.21

0.41

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.41

0.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

135

1246

1.09

0.40

2.8

3.3

u/ml

78.3

62.6

0.20

125

1205

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.47

0.40

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

132

1.29

0.40

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

441

4233

1.05

0.40

1.7

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

278

1.19

0.39

1.2

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.43

0.39

1.2

1.8

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.43

0.39

1.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

124

1.29

0.38

1.8

6.5

mg/l

62.6

69.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.39

0.38

1.2

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.39

0.38

1.0

1.1

umol/24h

1.7

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.39

0.38

13.4

6.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.35

0.37

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.35

0.37

1.0

2.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

431

1.14

0.36

1.1

1.2

u/ml

2.1

3.0

0.56

144

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

223

0.81

0.35

1.2

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

310

1.16

0.35

1.2

1.1

92.2

96.4

0.34

297

(3017704) Immunofixation for Urine

156

0.77

0.34

2.8

1.7

—

(3045788) Cell count panel - Pleural fluid

255

1.18

0.34

1.5

—

(4133840)

1.34

0.34

1.4

1.1

—

(3006462) Nitrate [Presence] in Urine

127

1.26

0.33

6.7

3.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

242

0.83

0.32

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

192

1.20

0.32

1.2

1.6

—

(4094501)

799

0.91

0.31

1.1

—

(1761868) Lipid panel - Serum or Plasma

1058

10785

0.97

0.31

3.0

2.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.72

0.30

1.3

1.2

g/l

—

0.3

—

(40765096) Chromosome analysis panel by Banding

0.71

0.30

1.0

1.1

—

(3033799) Differential panel - Peritoneal fluid

0.71

0.30

2.7

2.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.71

0.30

1.1

1.0

—

(3011436) Histone Ab [Units/volume] in Serum

1.30

0.30

1.1

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

104

967

1.08

0.29

1.7

1.6

mu/l

262.1

293.7

0.87

882

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

430

1.12

0.29

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

111

0.72

0.28

1.3

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

431

1.11

0.28

1.1

1.2

u/ml

4.5

4.1

0.14

201

(3044889) 12 lead EKG panel

2049

20281

1.02

0.27

4.0

3.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.28

0.26

1.0

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

348

1.12

0.25

1.4

1.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

123

1.22

0.25

1.1

1.0

84.5

95.6

—

(3007461) Platelets [#/volume] in Blood

3323

33090

1.03

0.25

28.8

19.3

e9/l

253.9

246.4

8.65

3266

32189

(3016650) Hepatitis A virus Ab [Presence] in Serum

487

0.90

0.25

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

105

1.24

0.24

1.1

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

142

1.20

0.24

1.7

2.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

180

0.83

0.24

1.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

422

0.90

0.23

2.2

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

289

2793

1.04

0.23

1.4

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.28

0.23

1.0

1.8

mg/l

0.9

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

2725

27407

0.98

0.22

20.2

14.1

40.0

40.1

0.18

1925

20097

(3043410) Blood group antigens tested for on Red Blood Cells

0.77

0.22

1.1

1.9

—

(3014891) Appearance of Pleural fluid

1.25

0.22

2.8

1.6

—

(3035941) MCH [Entitic mass]

3324

33114

1.03

0.22

28.7

19.2

30.3

30.4

2.18

3292

32590

(3024731) MCV [Entitic volume]

3324

33116

1.03

0.21

28.7

19.3

90.9

0.01

3292

32592

(4034850)

905

0.94

0.21

14.9

9.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

36.6

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

8.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

21.5

—

(3026361) Erythrocytes [#/volume] in Blood

3324

33121

1.03

0.20

28.8

19.3

e12/l

4.5

0.22

3260

32127

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.20

0.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.25

0.20

1.8

3.2

ng/l

91.0

111.5

—

(4035726)

254

2458

1.04

0.20

1.5

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

104

1097

0.95

0.20

2.0

1.7

mg/l

5.8

3.6

0.96

758

(3010813) Leukocytes [#/volume] in Blood

3325

33135

1.02

0.19

28.8

19.3

e9/l

7.1

6.7

23.71

3258

32136

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

510

1.08

0.19

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

146

1.16

0.19

1.2

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.22

0.19

2.2

1.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.13

0.18

1.7

2.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

3324

33131

1.02

0.18

28.9

19.4

g/l

136.0

136.6

1.57

3291

32610

(3023383) Lactate [Moles/volume] in Pleural fluid

1.22

0.17

1.5

1.4

mmol/l

3.2

3.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.18

0.16

1.1

—

(3034426) Prothrombin time (PT)

101

1.19

0.16

1.3

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

162

0.86

0.16

1.3

1.4

u/l

5.5

7.6

—

137

(3023323) Follitropin [Units/volume] in Serum or Plasma

106

1107

0.96

0.15

1.5

1.4

iu/l

22.7

25.5

0.41

946

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

312

1.09

0.15

2.1

1.6

—

(4268621)

297

0.91

0.15

2.2

2.3

—

(3022689) Creatine [Moles/volume] in Urine

0.75

0.15

1.7

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

362

3697

0.98

0.15

1.5

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

1.08

0.14

1.7

1.3

—

(44806420)

0.80

0.14

2.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

316

0.92

0.14

1.4

pmol/l

67.2

163.2

—

(4211845)

141

1.14

0.13

6.8

3.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

100

0.80

0.13

1.1

1.4

pmol/l

14.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

149

1446

1.03

0.12

1.4

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

882

8731

1.01

0.12

3.7

3.9

22.7

21.9

0.86

382

3914

(4281824)

279

1.08

0.11

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

629

6356

0.99

0.10

2.7

2.8

ug/l

0.8

0.01

376

3957

(3023410) Appearance of Cerebral spinal fluid

281

1.07

0.09

1.3

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

113

0.88

0.08

1.1

miu/ml

1736.2

1558.7

—

113

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.04

0.08

1.7

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.12

0.07

1.0

2.2

ug/l

1.3

1.1

0.13

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.80

0.07

1.5

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.08

0.07

7.5

7.2

—

(3008295) Osmolality of Serum or Plasma

294

1.05

0.07

1.5

mosm/kgh2o

280.2

280.1

0.01

224

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.02

0.07

1.3

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

1.12

0.06

1.7

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.86

0.06

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

305

3083

0.99

0.06

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

131

0.92

0.05

1.3

1.7

—

(40768795) Lymph node Pathology biopsy report

263

0.95

0.05

1.1

1.2

—

(3011648) Oxygen content in Venous blood

248

1.05

0.05

2.3

2.6

11.5

11.6

0.05

248

(1617658) Protocol used for examination of sentinel lymph nodes

199

1.06

0.04

1.0

—

(40768441) Liver Pathology biopsy report

211

0.95

0.04

1.4

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

563

0.98

0.03

1.5

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

935

1.02

0.03

1.4

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

141

1.06

0.03

9.7

3.5

—

(4027681)

163

1.04

0.01

1.0

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

263

1.03

0.01

3.4

5.2

u/ml

28.5

74.8

—

(40761536) Microorganisms panel - Urine sediment

237

2362

1.00

0.00

4.3

3.9

—

(3016018) Differential panel - Cerebral spinal fluid

295

1.02

0.00

1.1

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

208

1.01

0.00

2.1

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

484

0.99

0.00

1.4

1.5

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.4

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.01

0.00

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.4

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

2761.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.91

0.00

1.0

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

0.99

0.00

1.7

2.0

264.7

176.6

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.3

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.6

—

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.01

0.00

8.0

7.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.93

0.00

8.4

7.5

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

0.91

0.00

1.0

1.2

—

118.6

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

1.0

—

4.3

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

2.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_BRONCH and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_BRONCH	1.698 [1.51, 1.91]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.384

During the follow-up period (1.1.1998 — 31.12.2019), 1909 out of 5827 females with J10_BRONCH died.

Males

Parameter	HR [95% CI]	p-value
J10_BRONCH	2.105 [1.81, 2.44]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 1998 out of 5250 males with J10_BRONCH died.

Mortality risk

Mortality risk for people of age

years, who have J10_BRONCH.

N-year risk	Females	Males
1	0.114%	0.399%
5	1.039%	2.452%
10	2.624%	6.119%
15	5.02%	11.305%
20	8.786%	18.783%

Relationships between endpoints

↥

Index endpoint: J10_BRONCH – Bronchitis, not specified as acute or chronic

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Bronchitis, not specified as acute or chronic

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints